www.businesswire.com Open in urlscan Pro
184.24.28.52 Public Scan

Go To Rescan
Add Verdict Report

Submitted URL:
https://www2.biocom.org/e/54352/mRNA-Drug-Substance-Production/n5767x/1641789306/h/iacwuSb1-SFI5vOwhKbOSqekLdUtHe8tJD10F...
Effective URL:
https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-L...
Submission: On April 29 via api (April 29th 2024, 6:39:48 pm UTC) from DE — Scanned from DE

Summary HTTP 88 Redirects Links 54 Behaviour Indicators

Summary

This website contacted 27 IPs in 5 countries across 24 domains to perform 88 HTTP transactions. The main IP is 184.24.28.52, located in Amsterdam, Netherlands and belongs to AKAMAI-AS, US. The main domain is www.businesswire.com. The Cisco Umbrella rank of the primary domain is 63062.
TLS certificate: Issued by DigiCert TLS RSA SHA256 2020 CA1 on October 19th 2023. Valid for: a year.

This is the only time www.businesswire.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
1 1	18.208.125.13 18.208.125.13	14618 (AMAZON-AES) (AMAZON-AES)
54	184.24.28.52 184.24.28.52	16625 (AKAMAI-AS) (AKAMAI-AS)
1	172.67.74.152 172.67.74.152	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700:20:... 2606:4700:20::681a:69f	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700:440... 2606:4700:4400::ac40:9b77	13335 (CLOUDFLAR...) (CLOUDFLARENET)
2	2a00:1450:400... 2a00:1450:4001:806::2008	15169 (GOOGLE) (GOOGLE)
3	172.67.74.24 172.67.74.24	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	3.218.230.104 3.218.230.104	14618 (AMAZON-AES) (AMAZON-AES)
1	184.73.100.94 184.73.100.94	14618 (AMAZON-AES) (AMAZON-AES)
1	2606:4700::68... 2606:4700::6810:89d1	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700:440... 2606:4700:4400::6812:22e5	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700::68... 2606:4700::6811:afc9	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700::68... 2606:4700::6812:8d11	13335 (CLOUDFLAR...) (CLOUDFLARENET)
6	2606:4700::68... 2606:4700::6810:7674	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700::68... 2606:4700::6811:80ac	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700::68... 2606:4700::6810:4c8e	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2606:4700::68... 2606:4700::6812:f46c	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2001:4860:480... 2001:4860:4802:34::36	15169 (GOOGLE) (GOOGLE)
1	2a00:1450:400... 2a00:1450:400c:c02::9d	15169 (GOOGLE) (GOOGLE)
1	216.58.206.67 216.58.206.67	15169 (GOOGLE) (GOOGLE)
1	104.19.175.188 104.19.175.188	13335 (CLOUDFLAR...) (CLOUDFLARENET)
2	172.217.16.200 172.217.16.200	15169 (GOOGLE) (GOOGLE)
1	2a02:26f0:350... 2a02:26f0:3500:16::215:1484	20940 (AKAMAI-ASN1) (AKAMAI-ASN1)
4 5	2620:1ec:21::14 2620:1ec:21::14	8068 (MICROSOFT...) (MICROSOFT-CORP-MSN-AS-BLOCK)
1	13.107.42.14 13.107.42.14	8068 (MICROSOFT...) (MICROSOFT-CORP-MSN-AS-BLOCK)
1	2602:816:5001... 2602:816:5001::39	54113 (FASTLY) (FASTLY)
1	162.247.243.29 162.247.243.29	54113 (FASTLY) (FASTLY)
88	27

1 18.208.125.13 (Ashburn, United States) 1 redirects

ASN14618 (AMAZON-AES, US)
PTR: ec2-18-208-125-13.compute-1.amazonaws.com

www2.biocom.org	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

54 184.24.28.52 (Amsterdam, Netherlands)

ASN16625 (AKAMAI-AS, US)
PTR: a184-24-28-52.deploy.static.akamaitechnologies.com

www.businesswire.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
mms.businesswire.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 172.67.74.152 (United States)

ASN13335 (CLOUDFLARENET, US)

api.ipify.org	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700:20::681a:69f (United States)

ASN13335 (CLOUDFLARENET, US)

cdn.shareaholic.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700:4400::ac40:9b77 (United States)

ASN13335 (CLOUDFLARENET, US)

geolocation.onetrust.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:806::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 172.67.74.24 (United States)

ASN13335 (CLOUDFLARENET, US)

cdn.openshareweb.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 3.218.230.104 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-3-218-230-104.compute-1.amazonaws.com

analytics.shareaholic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 184.73.100.94 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-184-73-100-94.compute-1.amazonaws.com

www.shareaholic.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6810:89d1 (United States)

ASN13335 (CLOUDFLARENET, US)

js.hs-scripts.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700:4400::6812:22e5 (United States)

ASN13335 (CLOUDFLARENET, US)

js.hs-banner.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6811:afc9 (United States)

ASN13335 (CLOUDFLARENET, US)

js.hs-analytics.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6812:8d11 (United States)

ASN13335 (CLOUDFLARENET, US)

js.hsleadflows.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 2606:4700::6810:7674 (United States)

ASN13335 (CLOUDFLARENET, US)

js.hubspot.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
api.hubspot.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
cta-service-cms2.hubspot.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
track.hubspot.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
forms.hubspot.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6811:80ac (United States)

ASN13335 (CLOUDFLARENET, US)

js.hsadspixel.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6810:4c8e (United States)

ASN13335 (CLOUDFLARENET, US)

js.usemessages.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6812:f46c (United States)

ASN13335 (CLOUDFLARENET, US)

api.hubapi.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2001:4860:4802:34::36 (United States)

ASN15169 (GOOGLE, US)

region1.analytics.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:400c:c02::9d (Brussels, Belgium)

ASN15169 (GOOGLE, US)

stats.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 216.58.206.67 (United States)

ASN15169 (GOOGLE, US)
PTR: tzfraa-aa-in-f3.1e100.net

www.google.de	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 104.19.175.188 (None, )

ASN13335 (CLOUDFLARENET, US)

perf-na1.hsforms.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 172.217.16.200 (United States)

ASN15169 (GOOGLE, US)
PTR: fra16s65-in-f8.1e100.net

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a02:26f0:3500:16::215:1484 (Frankfurt am Main, Germany)

ASN20940 (AKAMAI-ASN1, NL)

snap.licdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 2620:1ec:21::14 (United States) 4 redirects

ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US)

px.ads.linkedin.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
www.linkedin.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 13.107.42.14 (United States)

ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US)

px4.ads.linkedin.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2602:816:5001::39 (United States)

ASN54113 (FASTLY, US)

js-agent.newrelic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 162.247.243.29 (United States)

ASN54113 (FASTLY, US)

bam.nr-data.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
54	businesswire.com www.businesswire.com — Cisco Umbrella Rank: 63062 mms.businesswire.com — Cisco Umbrella Rank: 60694	7 MB
6	linkedin.com 4 redirects px.ads.linkedin.com — Cisco Umbrella Rank: 328 www.linkedin.com — Cisco Umbrella Rank: 613 px4.ads.linkedin.com — Cisco Umbrella Rank: 6223	4 KB
6	hubspot.com js.hubspot.com — Cisco Umbrella Rank: 4170 api.hubspot.com — Cisco Umbrella Rank: 4845 cta-service-cms2.hubspot.com — Cisco Umbrella Rank: 4116 track.hubspot.com — Cisco Umbrella Rank: 2416 forms.hubspot.com — Cisco Umbrella Rank: 5487	30 KB
4	googletagmanager.com www.googletagmanager.com — Cisco Umbrella Rank: 39	368 KB
3	openshareweb.com cdn.openshareweb.com — Cisco Umbrella Rank: 27282	94 KB
2	shareaholic.net cdn.shareaholic.net — Cisco Umbrella Rank: 26775 www.shareaholic.net — Cisco Umbrella Rank: 25261	7 KB
1	nr-data.net bam.nr-data.net — Cisco Umbrella Rank: 242	628 B
1	newrelic.com js-agent.newrelic.com — Cisco Umbrella Rank: 594	10 KB
1	licdn.com snap.licdn.com — Cisco Umbrella Rank: 781	17 KB
1	hsforms.com perf-na1.hsforms.com — Cisco Umbrella Rank: 4475	926 B
1	google.de www.google.de — Cisco Umbrella Rank: 7278	63 B
1	doubleclick.net stats.g.doubleclick.net — Cisco Umbrella Rank: 84	258 B
1	google.com region1.analytics.google.com — Cisco Umbrella Rank: 2941	249 B
1	hubapi.com api.hubapi.com — Cisco Umbrella Rank: 3493	1 KB
1	usemessages.com js.usemessages.com — Cisco Umbrella Rank: 4787	25 KB
1	hsadspixel.net js.hsadspixel.net — Cisco Umbrella Rank: 3146	4 KB
1	hsleadflows.net js.hsleadflows.net — Cisco Umbrella Rank: 5216	88 KB
1	hs-analytics.net js.hs-analytics.net — Cisco Umbrella Rank: 2216	21 KB
1	hs-banner.com js.hs-banner.com — Cisco Umbrella Rank: 2206	17 KB
1	hs-scripts.com js.hs-scripts.com — Cisco Umbrella Rank: 2505	1 KB
1	shareaholic.com analytics.shareaholic.com — Cisco Umbrella Rank: 25867	384 B
1	onetrust.com geolocation.onetrust.com — Cisco Umbrella Rank: 535	237 B
1	ipify.org api.ipify.org — Cisco Umbrella Rank: 2959	164 B
1	biocom.org 1 redirects www2.biocom.org — Cisco Umbrella Rank: 880783	689 B
88	24

	Domain	Requested by
49	www.businesswire.com	www.businesswire.com
5	mms.businesswire.com	www.businesswire.com
4	px.ads.linkedin.com	3 redirects www.businesswire.com
4	www.googletagmanager.com	www.businesswire.com www.googletagmanager.com js.hsadspixel.net
3	cdn.openshareweb.com	cdn.shareaholic.net www.businesswire.com
2	api.hubspot.com	www.businesswire.com
1	bam.nr-data.net	js-agent.newrelic.com
1	forms.hubspot.com	www.businesswire.com
1	track.hubspot.com
1	js-agent.newrelic.com	www.businesswire.com
1	px4.ads.linkedin.com	www.businesswire.com
1	www.linkedin.com	1 redirects
1	snap.licdn.com	js.hsadspixel.net
1	perf-na1.hsforms.com	www.businesswire.com
1	www.google.de	www.businesswire.com
1	stats.g.doubleclick.net	www.googletagmanager.com
1	region1.analytics.google.com	www.googletagmanager.com
1	api.hubapi.com	www.businesswire.com
1	cta-service-cms2.hubspot.com	js.hubspot.com
1	js.usemessages.com	js.hs-scripts.com
1	js.hsadspixel.net	js.hs-scripts.com
1	js.hubspot.com	js.hs-scripts.com
1	js.hsleadflows.net	js.hs-scripts.com
1	js.hs-analytics.net	js.hs-scripts.com
1	js.hs-banner.com	js.hs-scripts.com
1	js.hs-scripts.com	www.googletagmanager.com
1	www.shareaholic.net	www.businesswire.com
1	analytics.shareaholic.com	cdn.openshareweb.com
1	geolocation.onetrust.com	www.businesswire.com
1	cdn.shareaholic.net	www.businesswire.com
1	api.ipify.org	www.businesswire.com
1	www2.biocom.org	1 redirects
88	32

This site contains links to these domains. Also see Links.

Domain
mms.businesswire.com
cts.businesswire.com
www.trilinkbiotech.com
www.linkedin.com
feed.businesswire.com
membership.businesswire.com
services.businesswire.com
blog.businesswire.com
newsroom.businesswire.com
twitter.com
www.businesswire.co.uk
www.businesswire.de
www.businesswire.fr
www.businesswire.hk
www.businesswire.it
www.businesswire.jp
www.tradeshownews.com
www.google.com
www.microsoft.com
www.mozilla.org
support.apple.com
cookiepedia.co.uk
onetrust.com

Subject Issuer	Validity	Valid
www.businesswire.com DigiCert TLS RSA SHA256 2020 CA1	`2023-10-19` - `2024-10-17`	a year	crt.sh
ipify.org GTS CA 1P5	`2024-03-21` - `2024-06-19`	3 months	crt.sh
shareaholic.net E1	`2024-04-14` - `2024-07-13`	3 months	crt.sh
onetrust.com Cloudflare Inc ECC CA-3	`2023-11-13` - `2024-11-12`	a year	crt.sh
*.google-analytics.com GTS CA 1C3	`2024-04-08` - `2024-07-01`	3 months	crt.sh
openshareweb.com GTS CA 1P5	`2024-03-17` - `2024-06-15`	3 months	crt.sh
shareaholic.com Amazon RSA 2048 M03	`2024-02-02` - `2025-03-02`	a year	crt.sh
*.shareaholic.net R3	`2024-04-21` - `2024-07-20`	3 months	crt.sh
hs-scripts.com E1	`2024-04-01` - `2024-06-30`	3 months	crt.sh
hs-banner.com E1	`2024-04-01` - `2024-06-30`	3 months	crt.sh
hs-analytics.net GTS CA 1P5	`2024-04-13` - `2024-07-12`	3 months	crt.sh
hsleadflows.net E1	`2024-04-05` - `2024-07-04`	3 months	crt.sh
hubspot.com Cloudflare Inc ECC CA-3	`2024-01-06` - `2024-12-31`	a year	crt.sh
hsadspixel.net E1	`2024-04-16` - `2024-07-15`	3 months	crt.sh
usemessages.com E1	`2024-04-12` - `2024-07-11`	3 months	crt.sh
hubapi.com E1	`2024-03-06` - `2024-06-04`	3 months	crt.sh
*.g.doubleclick.net GTS CA 1C3	`2024-04-08` - `2024-07-01`	3 months	crt.sh
*.google.de GTS CA 1C3	`2024-04-08` - `2024-07-01`	3 months	crt.sh
hsforms.com GTS CA 1P5	`2024-04-17` - `2024-07-16`	3 months	crt.sh
snap.licdn.com DigiCert SHA2 Secure Server CA	`2023-12-13` - `2024-12-12`	a year	crt.sh
www.linkedin.com DigiCert SHA2 Secure Server CA	`2024-01-30` - `2024-07-30`	6 months	crt.sh
js-agent.newrelic.com GlobalSign Atlas R3 DV TLS CA 2024 Q1	`2024-03-21` - `2025-04-22`	a year	crt.sh
*.nr-data.net DigiCert Global G2 TLS RSA SHA256 2020 CA1	`2023-09-29` - `2024-10-01`	a year	crt.sh

This page contains 1 frames:

Primary Page: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Frame ID: E8FDFE9CC933EB1806ED853F130CB043
Requests: 91 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page Title

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production | Business Wire

Page URL History Show full URLs

https://www2.biocom.org/e/54352/mRNA-Drug-Substance-Production/n5767x/1641789306/h/iacwuSb1-SFI5vOwh... HTTP 301
https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-... Page URL

Detected technologies

Akamai Bot Manager (Security) Expand

Overall confidence: 100%
Detected patterns

Google Analytics (Analytics) Expand

Overall confidence: 100%
Detected patterns

Google Tag Manager (Tag Managers) Expand

Overall confidence: 100%
Detected patterns

googletagmanager\.com/gtm\.js
googletagmanager\.com/gtag/js

HubSpot Analytics (Analytics) Expand

Overall confidence: 100%
Detected patterns

js\.hs-analytics\.net/analytics

Linkedin Insight Tag (Analytics) Expand

Overall confidence: 100%
Detected patterns

snap\.licdn\.com/li\.lms-analytics/insight\.min\.js

Modernizr (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

([\d.]+)?/modernizr(?:\.([\d.]+))?.*\.js

OneTrust (Cookie compliance) Expand

Overall confidence: 100%
Detected patterns

otSDKStub\.js

jQuery (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

jQuery UI (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery-ui.*\.js

Page Statistics

88
Requests

99 %
HTTPS

59 %
IPv6

24
Domains

32
Subdomains

27
IPs

5
Countries

7984 kB
Transfer

11172 kB
Size

29
Cookies

54 Outgoing links

These are links going to different origins than the main page.

URL: https://mms.businesswire.com/media/20240418722567/en/2102046/5/cGMP_MRNA_Group1_Ribbon.jpg?download=1

Search URL Search Domain Scan URL

URL: https://mms.businesswire.com/media/20240418722567/en/2102046/22/cGMP_MRNA_Group1_Ribbon.jpg?download=1
Title: Image

Search URL Search Domain Scan URL

URL: https://mms.businesswire.com/media/20240418722567/en/2102046/4/cGMP_MRNA_Group1_Ribbon.jpg?download=1
Title: Small

Search URL Search Domain Scan URL

URL: https://mms.businesswire.com/media/20240418722567/en/2102046/3/cGMP_MRNA_Group1_Ribbon.jpg?download=1
Title: Preview

Search URL Search Domain Scan URL

URL: https://mms.businesswire.com/media/20240418722567/en/2102046/2/cGMP_MRNA_Group1_Ribbon.jpg?download=1
Title: Thumbnail

Search URL Search Domain Scan URL

URL: https://mms.businesswire.com/media/20240418722567/en/2101950/22/TriLink_Logo_300x300_20221207.jpg?download=1
Title: Image

Search URL Search Domain Scan URL

URL: https://mms.businesswire.com/media/20240418722567/en/2101950/5/TriLink_Logo_300x300_20221207.jpg?download=1
Title: Full Size

Search URL Search Domain Scan URL

URL: https://mms.businesswire.com/media/20240418722567/en/2101950/4/TriLink_Logo_300x300_20221207.jpg?download=1
Title: Small

Search URL Search Domain Scan URL

URL: https://mms.businesswire.com/media/20240418722567/en/2101950/3/TriLink_Logo_300x300_20221207.jpg?download=1
Title: Preview

Search URL Search Domain Scan URL

URL: https://mms.businesswire.com/media/20240418722567/en/2101950/2/TriLink_Logo_300x300_20221207.jpg?download=1
Title: Thumbnail

Search URL Search Domain Scan URL

URL: https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.trilinkbiotech.com%2F&esheet=53937856&newsitemid=20240418722567&lan=en-US&anchor=TriLink+BioTechnologies&index=1&md5=3c5d2ff91dabbc16e0d7ea65b645b722
Title: TriLink BioTechnologies

Search URL Search Domain Scan URL

URL: https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.trilinkbiotech.com%2Fcgmp-mrna-manufacturing-facility&esheet=53937856&newsitemid=20240418722567&lan=en-US&anchor=cGMP+mRNA+manufacturing+facility&index=2&md5=3fc71383caabf1dc85e90a57f15b3763
Title: cGMP mRNA manufacturing facility

Search URL Search Domain Scan URL

URL: https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.trilinkbiotech.com%2Fgmp-mrna-manufacturing&esheet=53937856&newsitemid=20240418722567&lan=en-US&anchor=mRNA+manufacturing+capabilities&index=3&md5=c0f609efba75956451f44d7dce50b5d3
Title: mRNA manufacturing capabilities

Search URL Search Domain Scan URL

URL: https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.trilinkbiotech.com%2Fcleancap&esheet=53937856&newsitemid=20240418722567&lan=en-US&anchor=CleanCap%26%23174%3B+mRNA+capping+technology&index=4&md5=29f8b53640bf541cb7ad7eb76e23f660
Title: CleanCap® mRNA capping technology

Search URL Search Domain Scan URL

URL: https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.trilinkbiotech.com%2F&esheet=53937856&newsitemid=20240418722567&lan=en-US&anchor=trilinkbiotech.com&index=5&md5=8e708af46c655ed75b44b0c520339e7a
Title: trilinkbiotech.com

Search URL Search Domain Scan URL

URL: https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.trilinkbiotech.com%2F&esheet=53937856&newsitemid=20240418722567&lan=en-US&anchor=trilinkbiotech.com&index=6&md5=618a41ae7395b242201ecb48a8c3d21c
Title: trilinkbiotech.com

Search URL Search Domain Scan URL

URL: https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DDs8e7p_PfdqCJM8Kz1p8UVtwZkuSRcO3ikqBgEjOMC1k2BB_lAQeW49orS59OnXs-qFXySxoBWO66OQiQAr5ZU3iKHq6uUs3mW_80PwzXHpVnvD3KtKZr5Axyg8BmQs9hjJIR5-S4b4QNDdR_A0taFjXo5Ny5BfFMj1UowX11r0LVXOo0k2DZJJqUNYf5Sj1FgAp2yikzX53PAYaeq6MFpKXgp5vXGs5gZpWP2ALYJU%3D&esheet=53937856&newsitemid=20240418722567&lan=en-US&anchor=www.maravai.com&index=7&md5=a0fb4244249221d16bcad98f2e27e0b7
Title: www.maravai.com

Search URL Search Domain Scan URL

URL: https://www.trilinkbiotech.com/

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/company/trilink-biotechnologies-part-of-maravai-lifesciences/
Title: TriLink on LinkedIn

Search URL Search Domain Scan URL

URL: http://feed.businesswire.com/rss/home/company/TriLink+BioTechnologies/9DvtE3t9fogy1bieJJwUNQ==

Search URL Search Domain Scan URL

URL: https://membership.businesswire.com/choose-country
Title: Submit a Press Release

Search URL Search Domain Scan URL

URL: https://services.businesswire.com/
Title: Services

Search URL Search Domain Scan URL

URL: https://services.businesswire.com/resources-education
Title: Education

Search URL Search Domain Scan URL

URL: https://blog.businesswire.com/
Title: Blog

Search URL Search Domain Scan URL

URL: https://services.businesswire.com/distribution-analytics/distribution-lists
Title: Distribution & Media

Search URL Search Domain Scan URL

URL: https://services.businesswire.com/media-journalist-tools
Title: Media & Journalist Tools

Search URL Search Domain Scan URL

URL: https://services.businesswire.com/resources-education/sample-press-release
Title: Sample Press Release

Search URL Search Domain Scan URL

URL: https://services.businesswire.com/find-your-news-online
Title: Find Your News Online

Search URL Search Domain Scan URL

URL: https://services.businesswire.com/resources-education/disclosure-resources
Title: Disclosure Resources

Search URL Search Domain Scan URL

URL: https://services.businesswire.com/about-us
Title: About Us

Search URL Search Domain Scan URL

URL: https://membership.businesswire.com/sign-up
Title: Become a Member

Search URL Search Domain Scan URL

URL: https://services.businesswire.com/contact-us
Title: Contact Us

Search URL Search Domain Scan URL

URL: https://services.businesswire.com/careers
Title: Careers

Search URL Search Domain Scan URL

URL: https://newsroom.businesswire.com/
Title: Business Wire Newsroom

Search URL Search Domain Scan URL

URL: https://newsroom.businesswire.com/events
Title: Business Wire Events

Search URL Search Domain Scan URL

URL: http://twitter.com/businesswire/
Title: Twitter

Search URL Search Domain Scan URL

URL: http://www.linkedin.com/companies/business-wire
Title: LinkedIn

Search URL Search Domain Scan URL

URL: http://www.businesswire.co.uk/
Title: UK/Ireland

Search URL Search Domain Scan URL

URL: http://www.businesswire.de/
Title: Deutschland

Search URL Search Domain Scan URL

URL: http://www.businesswire.fr/
Title: France

Search URL Search Domain Scan URL

URL: http://www.businesswire.hk/?__hstc=241090844.647017c5d3545be16452baf791365a4e.1714415985481.1714415985481.1714415985481.1&__hssc=241090844.1.1714415985482&__hsfp=2492303821
Title: Hong Kong

Search URL Search Domain Scan URL

URL: http://www.businesswire.it/
Title: Italy

Search URL Search Domain Scan URL

URL: http://www.businesswire.jp/
Title: Japan

Search URL Search Domain Scan URL

URL: http://www.tradeshownews.com/
Title: Tradeshownews.com

Search URL Search Domain Scan URL

URL: http://newsroom.businesswire.com/contact
Title: Contact Us

Search URL Search Domain Scan URL

URL: https://services.businesswire.com/uk-tax-strategy-page
Title: UK Tax Strategy

Search URL Search Domain Scan URL

URL: https://services.businesswire.com/privacy
Title: Privacy Statement

Search URL Search Domain Scan URL

URL: https://www.google.com/chrome/
Title: Chrome

Search URL Search Domain Scan URL

URL: https://www.microsoft.com/edge
Title: Edge

Search URL Search Domain Scan URL

URL: https://www.mozilla.org/firefox/
Title: Firefox

Search URL Search Domain Scan URL

URL: https://support.apple.com/downloads/safari
Title: Safari

Search URL Search Domain Scan URL

URL: https://cookiepedia.co.uk/giving-consent-to-cookies
Title: More information

Search URL Search Domain Scan URL

URL: https://onetrust.com/poweredbyonetrust

Search URL Search Domain Scan URL

URL: https://services.businesswire.com/cookie-policy
Title: Cookie Policy

Search URL Search Domain Scan URL

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

https://www2.biocom.org/e/54352/mRNA-Drug-Substance-Production/n5767x/1641789306/h/iacwuSb1-SFI5vOwhKbOSqekLdUtHe8tJD10FqN8_ns HTTP 301
https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 83

https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=23320&time=1714415983890&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production HTTP 302
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=23320&time=1714415983890&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production&cookiesTest=true HTTP 302
https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D23320%26time%3D1714415983890%26url%3Dhttps%253A%252F%252Fwww.businesswire.com%252Fnews%252Fhome%252F20240418722567%252Fen%252FTriLink-BioTechnologies%2525C2%2525AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production%26cookiesTest%3Dtrue%26liSync%3Dtrue HTTP 302
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=23320&time=1714415983890&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production&cookiesTest=true&liSync=true HTTP 302
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=23320&time=1714415983890&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production&cookiesTest=true&liSync=true&e_ipv6=AQINJ_HS-cunQQAAAY8rJ-HuT9KmGRt5nMzUKSLGdHpFT1bUbA5_mn9WycYoq4ETWnCAtLg

88 HTTP transactions
4 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H/1.1

200
OK

Primary Request TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Show response
www.businesswire.com/news/home/20240418722567/en/
Redirect Chain

https://www2.biocom.org/e/54352/mRNA-Drug-Substance-Production/n5767x/1641789306/h/iacwuSb1-SFI5vOwhKbOSqekLdUtHe8tJD10FqN8_ns
https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production

80 KB
21 KB

525ms
251ms

Document
text/html

184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

d9cf9aea80a24544bae684ef622a395d42051e1e900e2129f95425b3567aee68

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self' frame-ancestors 'self' frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN SAMEORIGIN SAMEORIGIN
X-Xss-Protection	1; mode=block 1; mode=block

Request headers

Accept-Language: de-DE,de;q=0.9;q=0.9
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile: ?0
sec-ch-ua-platform: "Win32"

Response headers

Cache-Control: public, max-age=0, s-maxage=300000
Connection: keep-alive
Content-Encoding: gzip
Content-Length: 19904
Content-Security-Policy: frame-ancestors 'self' frame-ancestors 'self' frame-ancestors 'self'
Content-Type: text/html; charset=UTF-8
Date: Mon, 29 Apr 2024 18:39:40 GMT
Expires: Mon, 29 Apr 2024 18:39:40 GMT
Pragma: no-cache
Referrer-Policy: no-referrer-when-downgrade no-referrer-when-downgrade
Strict-Transport-Security: max-age=31536000; includeSubDomains max-age=31536000; includeSubDomains
Vary: Accept-Encoding
X-Akamai-Transformed: 9 20227 0 pmb=mTOE,4
X-Frame-Options: SAMEORIGIN SAMEORIGIN SAMEORIGIN
svr: 1
x-xss-protection: 1; mode=block 1; mode=block

Redirect headers

Connection: keep-alive
Content-Length: 213
Content-Type: text/html; charset=UTF-8
Date: Mon, 29 Apr 2024 18:39:39 GMT
X-Pardot-Route: e8229a0ff18ebffc83a98010d2521dd5
cache-control: max-age=63072000
content-encoding: gzip
expires: Wed, 29 Apr 2026 18:39:39 GMT
location: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
p3p: CP="NOI DSP COR CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT", policyref="/w3c/p3p.xml"
vary: Accept-Encoding,User-Agent

GET
H/1.1 200
OK style.css
www.businesswire.com/css/ 184 KB
37 KB 123ms
120ms Stylesheet
text/css 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/css/style.css

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

8740655e34cd23144f49dda59d5cad874835a934c80e835caeb484681730188b

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:40 GMT
Connection: keep-alive
Content-Length: 37242
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:06 GMT
ETag: "e0253-2df7b-614bccf625880"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/css
Cache-Control: max-age=56572
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 10:22:32 GMT

GET
H/1.1 200
OK jquery-ui.css
www.businesswire.com/css/ 32 KB
7 KB 255ms
105ms Stylesheet
text/css 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/css/jquery-ui.css

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

5a44c24e5cdefc089f1ba34fca62cc4fd3c6dbc76c003e5158ff04b71650680f

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:40 GMT
Connection: keep-alive
Content-Length: 6293
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:06 GMT
ETag: "e023e-7ecb-614bccf625880"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/css
Cache-Control: max-age=72280
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 14:44:20 GMT

GET
H/1.1 200
OK otSDKStub.js Show response
www.businesswire.com/js/one_trust/scripttemplates/ 13 KB
5 KB 275ms
102ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/one_trust/scripttemplates/otSDKStub.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

59f402de9f1e432c10350864d4d9a3f348bea192abfd0785e40f7ab1c49006ed

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:40 GMT
Connection: keep-alive
Content-Length: 4132
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "1205d8-33e7-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=71794
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 14:36:14 GMT

GET
H2 200 / Show response
api.ipify.org/ 29 B
164 B 311ms
220ms Script
application/javascript 172.67.74.152
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://api.ipify.org/?format=jsonp&callback=getIP
Requested by: Host: www.businesswire.com
URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 172.67.74.152 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: a4439732d3e10173e3682f38d05594feb616c0cb13e32ecb1dbe90df30ed05d3

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:40 GMT
cf-cache-status: DYNAMIC
server: cloudflare
cf-ray: 87c16a874f25a058-FRA
content-length: 29
vary: Origin
content-type: application/javascript

GET
H/1.1 200
OK modernizr-respond.js Show response
www.businesswire.com/js/libs/ 19 KB
8 KB 275ms
100ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/libs/modernizr-respond.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

160f46005c381ae6d37380b8810064ff98d2a09586effffa3be6c97321d28337

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:40 GMT
Connection: keep-alive
Content-Length: 7875
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e0f3c-4b90-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=71684
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 14:34:24 GMT

GET
H/1.1 200
OK functions.js Show response
www.businesswire.com/js/ 14 KB
5 KB 357ms
102ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/functions.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

7376cd5c5430a39705c5a36a379a4c6d4e1a135a70dadb2acaf34433af7948dc

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:40 GMT
Connection: keep-alive
Content-Length: 4171
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e0eaf-3600-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=65243
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 12:47:03 GMT

GET
H/1.1 200
OK popups.js Show response
www.businesswire.com/js/ 5 KB
2 KB 355ms
89ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/popups.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

2ead5b54346cb37b22ba40f601e300b439230b6ce7e3c1f290b198376b94ac01

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:40 GMT
Connection: keep-alive
Content-Length: 1341
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e0f4d-147e-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=70604
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 14:16:24 GMT

GET
H/1.1 200
OK jquery.js Show response
www.businesswire.com/js/ 90 KB
33 KB 373ms
104ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/jquery.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

c12f6098e641aaca96c60215800f18f5671039aecf812217fab3c0d152f6adb4

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:40 GMT
Connection: keep-alive
Content-Length: 32775
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e0ebc-169d5-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=24736
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 01:31:56 GMT

GET
H/1.1 200
OK jquery-ui.js Show response
www.businesswire.com/js/ 223 KB
60 KB 371ms
96ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/jquery-ui.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

77af9f377f6d1afc0a96def94af1b74560776364afbb060704476f44c8e32b89

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:40 GMT
Connection: keep-alive
Content-Length: 60437
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e0eba-37b29-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=71640
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 14:33:40 GMT

GET
H/1.1 200
OK bwjsapi.js Show response
www.businesswire.com/js/ 37 KB
10 KB 368ms
93ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/bwjsapi.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

1292fac55273c706261a683d6f48ec9f6da16faddbaa99227e32e9b673692ffb

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:40 GMT
Connection: keep-alive
Content-Length: 9307
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e0e67-9560-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=20230
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 00:16:50 GMT

GET
H2 200 shareaholic.js Show response
cdn.shareaholic.net/assets/pub/ 10 KB
5 KB 166ms
68ms Script
application/javascript 2606:4700:20::681a:69f
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.shareaholic.net/assets/pub/shareaholic.js
Requested by: Host: www.businesswire.com
URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::681a:69f , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: ccb9e784aeed749aace58c8ba9719928ce908e26650f9dfebb41fa1f31c1fb34

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:40 GMT
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 729
last-modified: Fri, 26 Jan 2024 16:19:55 GMT
server: cloudflare
etag: W/"aa281fefab8896725e86c225f47bb0a2"
x-shr-hello-human: This website grows faster with Shareaholic.
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=eH77b4VPhL8%2BiJ5mrO0yvIji06rcW3Ixb810B4YK0e4I%2B6nkH8fJAexetjNDsqQCmc2%2FHAqvk%2BvzTKlJ5VOanQuJl4kzVi67%2Fpjv3tLpLm9P%2BOxFSyWsaEFZlhKYQnXLOalGoMoTF937u%2FXDLw9aQOc%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: max-age=1200, public
vary: Accept-Encoding
x-shr-origin: S3
cf-ray: 87c16a874c1a4d58-FRA

GET
H/1.1 200
OK 4f48c7da Show response
www.businesswire.com/akam/13/ 26 KB
10 KB 330ms
330ms Script
application/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://www.businesswire.com/akam/13/4f48c7da
Requested by: Host: www.businesswire.com
URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_256_GCM
Server: 184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a184-24-28-52.deploy.static.akamaitechnologies.com
Software: /
Resource Hash: e7b589d3fb9953c32792c55e285b9e9a99c93e34bb06cc7a10a492e8005f74e8

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Pragma: no-cache
Date: Mon, 29 Apr 2024 18:39:41 GMT
Content-Encoding: gzip
Last-Modified: Thu, 22 Feb 2024 19:48:28 GMT
ETag: "dc4088dba416148ad2fd1c623d52c7a0f91edae49ba66f93fb905ed29e7ea0b8"
Stored-Attribute-Sha-Checksum: e7b589d3fb9953c32792c55e285b9e9a99c93e34bb06cc7a10a492e8005f74e8
Vary: Accept-Encoding
Content-Type: application/javascript
Cache-Control: max-age=21600
Connection: keep-alive
Content-Length: 8794
Expires: Mon, 29 Apr 2024 18:39:41 GMT

GET
H/1.1 200
OK bwlogo_extreme.png
www.businesswire.com/images/ 40 KB
40 KB 185ms
104ms Image
image/png 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.businesswire.com/images/bwlogo_extreme.png

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

4e64fd02b068942d828f95a048e9bd0f054ec691bd5daa53c023479e5822a9a4

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Referrer-Policy: no-referrer-when-downgrade
Date: Mon, 29 Apr 2024 18:39:40 GMT
Last-Modified: Thu, 28 Mar 2024 18:37:06 GMT
ETag: "e2014-9e2d-614bccf625880"
X-Frame-Options: SAMEORIGIN
Content-Type: image/png
Cache-Control: max-age=71596
Connection: keep-alive
Accept-Ranges: bytes
Content-Length: 40493
x-xss-protection: 1; mode=block
Expires: Tue, 30 Apr 2024 14:32:56 GMT

GET
H/1.1 200
OK jquery.nicescroll.min.js Show response
www.businesswire.com/js/libs/ 56 KB
16 KB 110ms
110ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/libs/jquery.nicescroll.min.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

e95a98f0bbe64814ce4f441ac53014c6cf9253eea073d63cec386c820fd245e4

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:40 GMT
Connection: keep-alive
Content-Length: 16074
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e0f3b-e146-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=75930
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 15:45:10 GMT

GET
H/1.1 200
OK mm_scrollbars.js Show response
www.businesswire.com/js/ 1 KB
1021 B 91ms
91ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/mm_scrollbars.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

999e300379aa7ca67f69307646f4b9fa5e17b4f433fec42f8ac2c3405bb9f745

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
Connection: keep-alive
Content-Length: 451
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e0f41-484-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=23392
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 01:09:33 GMT

GET
H/1.1 200
OK release_tables.js Show response
www.businesswire.com/js/ 3 KB
2 KB 96ms
95ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/release_tables.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

5c122e51cca6f4741ed0afab5d09ce6aeb923acec870795671dde211058dbe14

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
Connection: keep-alive
Content-Length: 992
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e0f58-acc-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=23305
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 01:08:06 GMT

GET
H/1.1 200
OK release_mm.js Show response
www.businesswire.com/js/ 13 KB
4 KB 513ms
511ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/release_mm.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

544ffef1524e6e64c299bc7547b545ea6e83a039c6bfa6716d062f19d82e3453

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
Connection: keep-alive
Content-Length: 3851
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e0f57-3270-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=68535
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 13:41:56 GMT

GET
H2 200 cGMP_MRNA_Group1_Ribbon.jpg
mms.businesswire.com/media/20240418722567/en/2102046/4/ 252 KB
253 KB 631ms
337ms Image
image/jpeg 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://mms.businesswire.com/media/20240418722567/en/2102046/4/cGMP_MRNA_Group1_Ribbon.jpg?download=1

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

/ Express

Resource Hash

d913314d16c18858c8ec347097b5a759202c694514b1f5b1138900dccd59e376

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000 ; includeSubDomains ; preload
X-Content-Type-Options	nosniff, nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:41 GMT
strict-transport-security: max-age=31536000 ; includeSubDomains ; preload
x-content-type-options: nosniff, nosniff
x-permitted-cross-domain-policies: none
x-requestid: undefined
x-powered-by: Express
x-frame-options: SAMEORIGIN, SAMEORIGIN
content-type: image/jpeg
content-disposition: inline; filename=cGMP_MRNA_Group1_Ribbon.jpg
content-length: 258388
x-xss-protection: 1

GET
H2 200 cGMP_MRNA_Group1_Ribbon.jpg
mms.businesswire.com/media/20240418722567/en/2102046/4/ 252 KB
253 KB 830ms
536ms Image
image/jpeg 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://mms.businesswire.com/media/20240418722567/en/2102046/4/cGMP_MRNA_Group1_Ribbon.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

/ Express

Resource Hash

d913314d16c18858c8ec347097b5a759202c694514b1f5b1138900dccd59e376

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000 ; includeSubDomains ; preload
X-Content-Type-Options	nosniff, nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-edgeconnect-origin-mex-latency: 131, 131
date: Mon, 29 Apr 2024 18:39:41 GMT
strict-transport-security: max-age=31536000 ; includeSubDomains ; preload
x-content-type-options: nosniff, nosniff
x-permitted-cross-domain-policies: none
x-requestid: undefined
x-edgeconnect-midmile-rtt: 77, 82
x-powered-by: Express
x-frame-options: SAMEORIGIN, SAMEORIGIN
content-type: image/jpeg
content-disposition: inline; filename=cGMP_MRNA_Group1_Ribbon.jpg
content-length: 258388
x-xss-protection: 1

GET
H2 200 TriLink_Logo_300x300_20221207.jpg
mms.businesswire.com/media/20240418722567/en/2101950/4/ 59 KB
60 KB 481ms
188ms Image
image/jpeg 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://mms.businesswire.com/media/20240418722567/en/2101950/4/TriLink_Logo_300x300_20221207.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

/ Express

Resource Hash

63b13cf4d4715751e7a6f35e73db896555a324da11c7e9369046ca540af9b16d

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000 ; includeSubDomains ; preload
X-Content-Type-Options	nosniff, nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:41 GMT
strict-transport-security: max-age=31536000 ; includeSubDomains ; preload
x-content-type-options: nosniff, nosniff
x-permitted-cross-domain-policies: none
x-requestid: undefined
x-powered-by: Express
x-frame-options: SAMEORIGIN, SAMEORIGIN
content-type: image/jpeg
content-disposition: inline; filename=TriLink_Logo_300x300_20221207.jpg
content-length: 60584
x-xss-protection: 1

GET
H2 200 TriLink_Logo_300x300_20221207.jpg
mms.businesswire.com/media/20240418722567/en/2101950/2/ 4 KB
5 KB 480ms
187ms Image
image/jpeg 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://mms.businesswire.com/media/20240418722567/en/2101950/2/TriLink_Logo_300x300_20221207.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

/ Express

Resource Hash

384c9762de94ebe33e5a318b8f96918eff10a446759851230ee14fd5e0680f4f

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000 ; includeSubDomains ; preload
X-Content-Type-Options	nosniff, nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-edgeconnect-origin-mex-latency: 62, 62, 62
date: Mon, 29 Apr 2024 18:39:41 GMT
strict-transport-security: max-age=31536000 ; includeSubDomains ; preload
x-content-type-options: nosniff, nosniff
x-permitted-cross-domain-policies: none
x-requestid: undefined
x-edgeconnect-midmile-rtt: 7, 82, 7
x-powered-by: Express
x-frame-options: SAMEORIGIN, SAMEORIGIN
content-type: image/jpeg
content-disposition: inline; filename=TriLink_Logo_300x300_20221207.jpg
content-length: 4264
x-xss-protection: 1

GET
H/1.1 200
OK video-js.js Show response
www.businesswire.com/js/ 673 KB
154 KB 114ms
112ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/video-js.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

ef60148bc712978f704ae42774e10d907623ac9b6c902f3fe2324b98e9505027

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
Connection: keep-alive
Content-Length: 156618
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e2041-a84e4-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=72142
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 14:42:03 GMT

GET
H/1.1 200
OK videojs-share.min.js Show response
www.businesswire.com/js/ 30 KB
11 KB 108ms
107ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/videojs-share.min.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

44e86a2b4711544b0ae7473d2a02df540d187f22bbe12207b1609d0d98ebbb00

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
Connection: keep-alive
Content-Length: 10686
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e1607-7783-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=71606
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 14:33:07 GMT

GET
H/1.1 200
OK videojs-ie8.min.js Show response
www.businesswire.com/js/ 27 KB
9 KB 96ms
96ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/videojs-ie8.min.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

3cea9fd4486e2820f34fdeb7970fd29c4fa531e79a285bf58aaab1ecdadfa99a

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
Connection: keep-alive
Content-Length: 8924
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e15f5-6a8f-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=23873
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 01:17:34 GMT

GET
H/1.1 200
OK videojs.ga.min.js Show response
www.businesswire.com/js/ 3 KB
2 KB 107ms
107ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/videojs.ga.min.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

e2207ea7a0d72c394c9ce7555a69763c10395c5a9997304b41bbe5e26a110c05

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
Connection: keep-alive
Content-Length: 1175
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e2033-a27-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=23905
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 01:18:06 GMT

GET
H/1.1 200
OK nav.js Show response
www.businesswire.com/js/ 2 KB
1 KB 106ms
106ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/nav.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

79a3aadaba2d00b96ec13a178496db6d5f616843b680c54999771d428e8bf036

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
Connection: keep-alive
Content-Length: 690
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e0f4b-6f2-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=24224
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 01:23:25 GMT

GET
H/1.1 200
OK icon_search.gif
www.businesswire.com/images/icons/ 549 B
1 KB 91ms
90ms Image
image/gif 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.businesswire.com/images/icons/icon_search.gif

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

65cae6aa6d59effeb9862295ba393b95f732132585c3ac485b24d9d89b3682c8

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Referrer-Policy: no-referrer-when-downgrade
Date: Mon, 29 Apr 2024 18:39:41 GMT
Last-Modified: Thu, 28 Mar 2024 18:37:06 GMT
ETag: "e05f5-225-614bccf625880"
X-Frame-Options: SAMEORIGIN
Content-Type: image/gif
Cache-Control: max-age=71238
Connection: keep-alive
Accept-Ranges: bytes
Content-Length: 549
x-xss-protection: 1; mode=block
Expires: Tue, 30 Apr 2024 14:26:59 GMT

GET
H/1.1 200
OK search.js Show response
www.businesswire.com/js/ 5 KB
2 KB 99ms
99ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/search.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

3d6807fc075e51181cfa831c0c38292fb20500d388104dd3737fb4665766ba83

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
Connection: keep-alive
Content-Length: 1663
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e0f5b-12c8-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=20357
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 00:18:58 GMT

GET
H/1.1 200
OK controls.js Show response
www.businesswire.com/js/ 2 KB
1 KB 90ms
90ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/controls.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

26737eb2a51a431a75507b3546e5d16a2d134c20ef3a9843ff74a759cf6eaec4

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
Connection: keep-alive
Content-Length: 762
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "e0ea0-7a9-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=71467
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 14:30:48 GMT

GET
H/1.1 200
OK icon-close-default.svg
www.businesswire.com/images/icons/ 517 B
1 KB 100ms
100ms Image
image/svg+xml 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.businesswire.com/images/icons/icon-close-default.svg

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

f05e5391999dffc4d9c41c055f0e1b28b04e1fed3adcb3c8c88d8ccc09434fa1

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Referrer-Policy: no-referrer-when-downgrade
Date: Mon, 29 Apr 2024 18:39:41 GMT
Last-Modified: Thu, 28 Mar 2024 18:37:06 GMT
ETag: "ebc34-205-614bccf625880"
X-Frame-Options: SAMEORIGIN
Content-Type: image/svg+xml
Cache-Control: max-age=22761
Connection: keep-alive
Accept-Ranges: bytes
Content-Length: 517
x-xss-protection: 1; mode=block
Expires: Tue, 30 Apr 2024 00:59:02 GMT

GET
H/1.1 200
OK a2007379-c22b-41e8-8743-1bbfd2cbb24a.json Show response
www.businesswire.com/js/one_trust/consent/a2007379-c22b-41e8-8743-1bbfd2cbb24a/ 3 KB
4 KB 190ms
188ms XHR
application/json 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/one_trust/consent/a2007379-c22b-41e8-8743-1bbfd2cbb24a/a2007379-c22b-41e8-8743-1bbfd2cbb24a.json

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/js/one_trust/scripttemplates/otSDKStub.js

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

b94f3186c80581ee9c963ad18f50b717d47f9c7c233b36752138da0748db4b72

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Referrer-Policy: no-referrer-when-downgrade
Date: Mon, 29 Apr 2024 18:39:41 GMT
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "1205ce-a70-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Content-Type: application/json
Connection: keep-alive
Accept-Ranges: bytes
Content-Length: 2672
x-xss-protection: 1; mode=block

GET
H2 200 location Show response
geolocation.onetrust.com/cookieconsentpub/v1/geo/ 70 B
237 B 170ms
78ms Script
text/javascript 2606:4700:4400::ac40:9b77
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://geolocation.onetrust.com/cookieconsentpub/v1/geo/location

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/js/one_trust/scripttemplates/otSDKStub.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:4400::ac40:9b77 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

cea2053be8e509589fe917b989317c05a16799e2d89ed1ea89b21870e3153631

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:41 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
server: cloudflare
cf-ray: 87c16a8a7918372d-FRA
vary: Accept-Encoding
content-type: text/javascript

GET
H/1.1 200
OK BWLogo.svg
www.businesswire.com/images/ 7 KB
7 KB 142ms
101ms Image
image/svg+xml 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.businesswire.com/images/BWLogo.svg

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/css/style.css

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

bd44792aa439f4567cd92bf7a3e0ce291c4702c7a66555257112c5942cfcce32

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/css/style.css
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Referrer-Policy: no-referrer-when-downgrade
Date: Mon, 29 Apr 2024 18:39:41 GMT
Last-Modified: Thu, 28 Mar 2024 18:37:06 GMT
ETag: "e1fd2-1a7d-614bccf625880"
X-Frame-Options: SAMEORIGIN
Content-Type: image/svg+xml
Cache-Control: max-age=72023
Connection: keep-alive
Accept-Ranges: bytes
Content-Length: 6781
x-xss-protection: 1; mode=block
Expires: Tue, 30 Apr 2024 14:40:04 GMT

GET
H/1.1 200
OK otBannerSdk.js Show response
www.businesswire.com/js/one_trust/scripttemplates/6.4.0/ 324 KB
68 KB 110ms
110ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/one_trust/scripttemplates/6.4.0/otBannerSdk.js

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/js/one_trust/scripttemplates/otSDKStub.js

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

d165f84e466f4d1c4e4840e7bddf5e6e0114e114cf2c555078c40719498430dc

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
Connection: keep-alive
Content-Length: 69031
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "14074b-51101-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/javascript
Cache-Control: max-age=69678
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 14:00:59 GMT

GET
H/1.1 200
OK en.json Show response
www.businesswire.com/js/one_trust/consent/a2007379-c22b-41e8-8743-1bbfd2cbb24a/ca650bff-f754-4f69-8955-abc81aeef0f5/ 29 KB
30 KB 203ms
203ms Fetch
application/json 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/one_trust/consent/a2007379-c22b-41e8-8743-1bbfd2cbb24a/ca650bff-f754-4f69-8955-abc81aeef0f5/en.json

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/js/one_trust/scripttemplates/6.4.0/otBannerSdk.js

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

2c2ccaf86d3c9c0567eedcf03068c2e8e3df5481d5775f2163ae0543d104390c

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Referrer-Policy: no-referrer-when-downgrade
Date: Mon, 29 Apr 2024 18:39:41 GMT
Last-Modified: Thu, 28 Mar 2024 18:37:08 GMT
ETag: "140725-7496-614bccf80dd00"
X-Frame-Options: SAMEORIGIN
Content-Type: application/json
Connection: keep-alive
Accept-Ranges: bytes
Content-Length: 29846
x-xss-protection: 1; mode=block

GET
H/1.1 200
OK ;portal.JSESSIONID=LkgqNj3Q1ph8gZRXgIT4PKQvyxbAArZB231S5OtKgFFpExDZLQ76!-93462612!389315169 Show response
www.businesswire.com/portal/site/home/template.BINARYPORTLET/permalink/resource.process/ 2 KB
3 KB 673ms
673ms XHR
text/html 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/portal/site/home/template.BINARYPORTLET/permalink/resource.process/;portal.JSESSIONID=LkgqNj3Q1ph8gZRXgIT4PKQvyxbAArZB231S5OtKgFFpExDZLQ76!-93462612!389315169?javax.portlet.tpst=e8d55157ef2522ec12306b100d908a0c&javax.portlet.prp_e8d55157ef2522ec12306b100d908a0c_releaseid=20240418722567&javax.portlet.prp_e8d55157ef2522ec12306b100d908a0c_mmgroupid=&javax.portlet.prp_e8d55157ef2522ec12306b100d908a0c_language=en&javax.portlet.rst_e8d55157ef2522ec12306b100d908a0c_displayLanguage=en&javax.portlet.rst_e8d55157ef2522ec12306b100d908a0c_displayReleaseId=20240418722567&javax.portlet.rst_e8d55157ef2522ec12306b100d908a0c_language=en&javax.portlet.rid_e8d55157ef2522ec12306b100d908a0c=recentStories&javax.portlet.rcl_e8d55157ef2522ec12306b100d908a0c=cacheLevelPage&javax.portlet.begCacheTok=com.vignette.cachetoken&javax.portlet.endCacheTok=com.vignette.cachetoken

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/js/jquery.js

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

394923a78cddce689b8ab8f8a7b059db4dbc69efe1d9754e5264da42e396a142

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self', frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Accept: text/html, */*; q=0.01
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
X-Requested-With: XMLHttpRequest
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self', frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:42 GMT
svr: 1
Connection: keep-alive
Content-Length: 817
x-xss-protection: 1; mode=block
Pragma: no-cache
X-Vignette-RespondedWith: AJAX
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Mon, 29 Apr 2024 18:39:42 GMT
X-Frame-Options: SAMEORIGIN, SAMEORIGIN
Vary: Accept-Encoding
Content-Language: en
Content-Type: text/html; charset=UTF-8
Cache-Control: public, max-age=120
X-Akamai-Transformed: 9 823 0 pmb=mTOE,2
Expires: Mon, 29 Apr 2024 18:41:42 GMT

GET
H/1.1 200
OK ;portal.JSESSIONID=LkgqNj3Q1ph8gZRXgIT4PKQvyxbAArZB231S5OtKgFFpExDZLQ76!-93462612!389315169 Show response
www.businesswire.com/portal/site/home/template.BINARYPORTLET/permalink/resource.process/ 942 B
2 KB 358ms
358ms XHR
text/html 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/portal/site/home/template.BINARYPORTLET/permalink/resource.process/;portal.JSESSIONID=LkgqNj3Q1ph8gZRXgIT4PKQvyxbAArZB231S5OtKgFFpExDZLQ76!-93462612!389315169?javax.portlet.tpst=e8d55157ef2522ec12306b100d908a0c&javax.portlet.prp_e8d55157ef2522ec12306b100d908a0c_releaseid=20240418722567&javax.portlet.prp_e8d55157ef2522ec12306b100d908a0c_mmgroupid=&javax.portlet.prp_e8d55157ef2522ec12306b100d908a0c_language=en&javax.portlet.rst_e8d55157ef2522ec12306b100d908a0c_displayLanguage=en&javax.portlet.rst_e8d55157ef2522ec12306b100d908a0c_displayReleaseId=20240418722567&javax.portlet.rst_e8d55157ef2522ec12306b100d908a0c_language=en&javax.portlet.rid_e8d55157ef2522ec12306b100d908a0c=releaseVersions&javax.portlet.rcl_e8d55157ef2522ec12306b100d908a0c=cacheLevelPage&javax.portlet.begCacheTok=com.vignette.cachetoken&javax.portlet.endCacheTok=com.vignette.cachetoken

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/js/jquery.js

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

b48ddcc94cd14256080b932013e806e9ff7df8a3bc61d556f380b85ecdff08de

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self', frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Accept: text/html, */*; q=0.01
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
X-Requested-With: XMLHttpRequest
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self', frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
svr: 1
Connection: keep-alive
Content-Length: 297
x-xss-protection: 1; mode=block
Pragma: no-cache
X-Vignette-RespondedWith: AJAX
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Mon, 29 Apr 2024 18:39:41 GMT
X-Frame-Options: SAMEORIGIN, SAMEORIGIN
Vary: Accept-Encoding
Content-Language: en
Content-Type: text/html; charset=UTF-8
Cache-Control: public, max-age=120
Expires: Mon, 29 Apr 2024 18:41:41 GMT

GET
H/1.1 200
OK ;portal.JSESSIONID=LkgqNj3Q1ph8gZRXgIT4PKQvyxbAArZB231S5OtKgFFpExDZLQ76!-93462612!389315169 Show response
www.businesswire.com/portal/site/home/template.BINARYPORTLET/permalink/resource.process/ 1 KB
3 KB 202ms
201ms XHR
text/html 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/portal/site/home/template.BINARYPORTLET/permalink/resource.process/;portal.JSESSIONID=LkgqNj3Q1ph8gZRXgIT4PKQvyxbAArZB231S5OtKgFFpExDZLQ76!-93462612!389315169?javax.portlet.tpst=e8d55157ef2522ec12306b100d908a0c&javax.portlet.prp_e8d55157ef2522ec12306b100d908a0c_releaseid=20240418722567&javax.portlet.prp_e8d55157ef2522ec12306b100d908a0c_mmgroupid=&javax.portlet.prp_e8d55157ef2522ec12306b100d908a0c_language=en&javax.portlet.rst_e8d55157ef2522ec12306b100d908a0c_displayLanguage=en&javax.portlet.rst_e8d55157ef2522ec12306b100d908a0c_displayReleaseId=20240418722567&javax.portlet.rst_e8d55157ef2522ec12306b100d908a0c_language=en&javax.portlet.rid_e8d55157ef2522ec12306b100d908a0c=companyInformation&javax.portlet.rcl_e8d55157ef2522ec12306b100d908a0c=cacheLevelPage&javax.portlet.begCacheTok=com.vignette.cachetoken&javax.portlet.endCacheTok=com.vignette.cachetoken

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/js/jquery.js

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

862722f46f838afdc87b0d0e4439876d506b1ef87733031b5066077405eb11e8

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self', frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Accept: text/html, */*; q=0.01
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
X-Requested-With: XMLHttpRequest
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self', frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
svr: 1
Connection: keep-alive
Content-Length: 564
x-xss-protection: 1; mode=block
Pragma: no-cache
X-Vignette-RespondedWith: AJAX
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Mon, 29 Apr 2024 18:39:41 GMT
X-Frame-Options: SAMEORIGIN, SAMEORIGIN
Vary: Accept-Encoding
Content-Language: en
Content-Type: text/html; charset=UTF-8
Cache-Control: public, max-age=120
X-Akamai-Transformed: 9 571 0 pmb=mTOE,2
Expires: Mon, 29 Apr 2024 18:41:41 GMT

GET
H/1.1 200
OK video-js.css
www.businesswire.com/css/ 54 KB
15 KB 101ms
100ms Stylesheet
text/css 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/css/video-js.css

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/js/video-js.js

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

f644de3220065939b8cdc51ef1bd230544eecf0d4500bd243a7b87c6457072fd

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Content-Encoding: gzip
Date: Mon, 29 Apr 2024 18:39:41 GMT
Connection: keep-alive
Content-Length: 14416
x-xss-protection: 1; mode=block
Referrer-Policy: no-referrer-when-downgrade
Last-Modified: Thu, 28 Mar 2024 18:37:06 GMT
ETag: "e1fad-d6ad-614bccf625880"
X-Frame-Options: SAMEORIGIN
Vary: Accept-Encoding
Content-Type: text/css
Cache-Control: max-age=20191
Accept-Ranges: bytes
Expires: Tue, 30 Apr 2024 00:16:12 GMT

GET
H/1.1 200
OK icon_x_23x19.png
www.businesswire.com/images/icons/ 1 KB
3 KB 88ms
88ms Image
image/png 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.businesswire.com/images/icons/icon_x_23x19.png

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/css/style.css

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

583ba596c46372b6751d507217532d8d87e370eddcfa5a76eebf02ff2797dee9

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/css/style.css
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Referrer-Policy: no-referrer-when-downgrade
Date: Mon, 29 Apr 2024 18:39:41 GMT
Last-Modified: Thu, 28 Mar 2024 18:37:06 GMT
ETag: "1e4787-590-614bccf625880"
X-Frame-Options: SAMEORIGIN
Content-Type: image/png
Cache-Control: max-age=71398
Connection: keep-alive
Accept-Ranges: bytes
Content-Length: 1424
x-xss-protection: 1; mode=block
Expires: Tue, 30 Apr 2024 14:29:39 GMT

GET
H/1.1 200
OK social-icon-linkedin.png
www.businesswire.com/css/images/ 3 KB
4 KB 176ms
96ms Image
image/png 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.businesswire.com/css/images/social-icon-linkedin.png

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/css/style.css

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

bb7be111d85833cbc191b8245763228cb73a79ecfad1c75b73e6fc54751780fd

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/css/style.css
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Referrer-Policy: no-referrer-when-downgrade
Date: Mon, 29 Apr 2024 18:39:41 GMT
Last-Modified: Thu, 28 Mar 2024 18:37:06 GMT
ETag: "e1fba-ad3-614bccf625880"
X-Frame-Options: SAMEORIGIN
Content-Type: image/png
Cache-Control: max-age=82055
Connection: keep-alive
Accept-Ranges: bytes
Content-Length: 2771
x-xss-protection: 1; mode=block
Expires: Tue, 30 Apr 2024 17:27:16 GMT

GET
H/1.1 200
OK icons_banner.png
www.businesswire.com/images/icons/ 4 KB
5 KB 172ms
96ms Image
image/png 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.businesswire.com/images/icons/icons_banner.png

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/css/style.css

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

b449d269937be5334690a493ebb4c9eeb61e6b9f1d82242848a4f00f8d3e04fd

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/css/style.css
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Referrer-Policy: no-referrer-when-downgrade
Date: Mon, 29 Apr 2024 18:39:41 GMT
Last-Modified: Thu, 28 Mar 2024 18:37:06 GMT
ETag: "e065a-1130-614bccf625880"
X-Frame-Options: SAMEORIGIN
Content-Type: image/png
Cache-Control: max-age=70265
Connection: keep-alive
Accept-Ranges: bytes
Content-Length: 4400
x-xss-protection: 1; mode=block
Expires: Tue, 30 Apr 2024 14:10:46 GMT

GET
H/1.1 200
OK icon_x_32x32.png
www.businesswire.com/images/icons/ 1 KB
2 KB 101ms
101ms Image
image/png 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.businesswire.com/images/icons/icon_x_32x32.png

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/css/style.css

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

03405acadb7c4a481c8aee9b80d66cac28eee181777c582666bb348842604511

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/css/style.css
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Security-Policy: frame-ancestors 'self'
Referrer-Policy: no-referrer-when-downgrade
Date: Mon, 29 Apr 2024 18:39:41 GMT
Last-Modified: Thu, 28 Mar 2024 18:37:06 GMT
ETag: "1e2938-5b7-614bccf625880"
X-Frame-Options: SAMEORIGIN
Content-Type: image/png
Cache-Control: max-age=71567
Connection: keep-alive
Accept-Ranges: bytes
Content-Length: 1463
x-xss-protection: 1; mode=block
Expires: Tue, 30 Apr 2024 14:32:28 GMT

GET
H2 200 icon_linkedin_32x32.png
www.businesswire.com/images/icons/ 1 KB
2 KB 225ms
225ms Image
image/png 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.businesswire.com/images/icons/icon_linkedin_32x32.png

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/css/style.css

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

43d2ea70980428c7bd3450733b800bfb9101cefda018b2be9d4a30c1a74bcf73

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/css/style.css
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000; includeSubDomains
content-security-policy: frame-ancestors 'self'
referrer-policy: no-referrer-when-downgrade
date: Mon, 29 Apr 2024 18:39:41 GMT
last-modified: Thu, 28 Mar 2024 18:37:06 GMT
etag: "e058d-55a-614bccf625880"
x-frame-options: SAMEORIGIN
content-type: image/png
cache-control: max-age=69060
accept-ranges: bytes
content-length: 1370
x-xss-protection: 1; mode=block
expires: Tue, 30 Apr 2024 13:50:41 GMT

GET
DATA 200
OK truncated
/ 9 KB
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: d554361630709572f4c9e33d02ca5ae56275756099a62195513017a0421f73c2

Request headers

Accept-Language: de-DE,de;q=0.9;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

Content-Type: image/png

GET
DATA 200
OK truncated
/ 157 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 80d54533f80e8233621f965ae0a7713928bdb4d491ed0eb5e90434550f1894cb

Request headers

Accept-Language: de-DE,de;q=0.9;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

Content-Type: image/png

GET
H2 200 cGMP_MRNA_Group1_Ribbon.jpg
mms.businesswire.com/media/20240418722567/en/2102046/5/ 6 MB
6 MB 351ms
351ms Image
image/jpeg 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://mms.businesswire.com/media/20240418722567/en/2102046/5/cGMP_MRNA_Group1_Ribbon.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

/ Express

Resource Hash

50c3445d60e69648d4cd175d8c25ad468b74bc6417d759d0dcd6e2900d75a2b4

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000 ; includeSubDomains ; preload
X-Content-Type-Options	nosniff, nosniff
X-Frame-Options	SAMEORIGIN, SAMEORIGIN
X-Xss-Protection	1

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:41 GMT
strict-transport-security: max-age=31536000 ; includeSubDomains ; preload
x-content-type-options: nosniff, nosniff
x-permitted-cross-domain-policies: none
x-requestid: undefined
x-powered-by: Express
x-frame-options: SAMEORIGIN, SAMEORIGIN
content-type: image/jpeg
content-disposition: inline; filename=cGMP_MRNA_Group1_Ribbon.jpg
content-length: 6163782
x-xss-protection: 1

GET
H2 200 ndm_cic.js Show response
www.businesswire.com/js/ 4 KB
2 KB 236ms
235ms XHR
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/ndm_cic.js?_=1714415981039

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/js/jquery.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

6f8cb50fd5444f23bb27d277556784564900d874695d094fea75ed25015388ab

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Accept: text/javascript, application/javascript, application/ecmascript, application/x-ecmascript, */*; q=0.01
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
X-Requested-With: XMLHttpRequest
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000; includeSubDomains
content-security-policy: frame-ancestors 'self'
referrer-policy: no-referrer-when-downgrade
date: Mon, 29 Apr 2024 18:39:41 GMT
last-modified: Thu, 28 Mar 2024 18:37:08 GMT
content-encoding: gzip
etag: "e0f4d-106f-614bccf80dd00"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: text/javascript
cache-control: max-age=75552
accept-ranges: bytes
content-length: 1363
x-xss-protection: 1; mode=block
expires: Tue, 30 Apr 2024 15:38:53 GMT

GET
H2 200 icon_stocks.gif
www.businesswire.com/images/icons/ 148 B
448 B 247ms
246ms Image
image/gif 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.businesswire.com/images/icons/icon_stocks.gif

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

4f244d61d858432e51d682e05fb338027daf4c2558f59e62ee44cbc2b712e533

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000; includeSubDomains
content-security-policy: frame-ancestors 'self'
referrer-policy: no-referrer-when-downgrade
date: Mon, 29 Apr 2024 18:39:42 GMT
last-modified: Thu, 28 Mar 2024 18:37:06 GMT
etag: "e0621-94-614bccf625880"
x-frame-options: SAMEORIGIN
content-type: image/gif
cache-control: max-age=68416
accept-ranges: bytes
content-length: 148
x-xss-protection: 1; mode=block
expires: Tue, 30 Apr 2024 13:39:58 GMT

GET
H2 200 icon_filings.gif
www.businesswire.com/images/icons/ 225 B
524 B 248ms
248ms Image
image/gif 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.businesswire.com/images/icons/icon_filings.gif

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

cb3792e01b1fd70d69acf5d1483a5f97f194334cd7569be64d6241de05088ce5

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000; includeSubDomains
content-security-policy: frame-ancestors 'self'
referrer-policy: no-referrer-when-downgrade
date: Mon, 29 Apr 2024 18:39:42 GMT
last-modified: Thu, 28 Mar 2024 18:37:06 GMT
etag: "e0555-e1-614bccf625880"
x-frame-options: SAMEORIGIN
content-type: image/gif
cache-control: max-age=24825
accept-ranges: bytes
content-length: 225
x-xss-protection: 1; mode=block
expires: Tue, 30 Apr 2024 01:33:27 GMT

GET
H2 200 otFlat.json Show response
www.businesswire.com/js/one_trust/scripttemplates/6.4.0/assets/ 12 KB
13 KB 337ms
336ms Fetch
application/json 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/one_trust/scripttemplates/6.4.0/assets/otFlat.json

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/js/one_trust/scripttemplates/6.4.0/otBannerSdk.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

ae407e415a45b6c720d8d61fef8c28756883d0f546a64e7a2969d6174c669951

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000; includeSubDomains
content-security-policy: frame-ancestors 'self'
referrer-policy: no-referrer-when-downgrade
date: Mon, 29 Apr 2024 18:39:42 GMT
last-modified: Thu, 28 Mar 2024 18:37:08 GMT
etag: "1205dd-3127-614bccf80dd00"
x-frame-options: SAMEORIGIN
content-type: application/json
accept-ranges: bytes
content-length: 12583
x-xss-protection: 1; mode=block

GET
H2 200 otPcCenter.json Show response
www.businesswire.com/js/one_trust/scripttemplates/6.4.0/assets/ 61 KB
62 KB 337ms
337ms Fetch
application/json 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/one_trust/scripttemplates/6.4.0/assets/otPcCenter.json

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/js/one_trust/scripttemplates/6.4.0/otBannerSdk.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

2f5bf5edcefe950e16d287cdcb9c28690952439098ee0639f4a960fe268ae231

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000; includeSubDomains
content-security-policy: frame-ancestors 'self'
referrer-policy: no-referrer-when-downgrade
date: Mon, 29 Apr 2024 18:39:42 GMT
last-modified: Thu, 28 Mar 2024 18:37:08 GMT
etag: "1205a2-f48b-614bccf80dd00"
x-frame-options: SAMEORIGIN
content-type: application/json
accept-ranges: bytes
content-length: 62603
x-xss-protection: 1; mode=block

POST
H2 200 pixel_4f48c7da Show response
www.businesswire.com/akam/13/ 0
565 B 139ms
125ms XHR
text/html 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://www.businesswire.com/akam/13/pixel_4f48c7da
Requested by: Host: www.businesswire.com
URL: https://www.businesswire.com/akam/13/4f48c7da
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a184-24-28-52.deploy.static.akamaitechnologies.com
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: application/x-www-form-urlencoded

Response headers

date: Mon, 29 Apr 2024 18:39:42 GMT
content-length: 0
content-type: text/html

GET
H2 200 toggle_obj.js Show response
www.businesswire.com/js/ 6 KB
2 KB 120ms
116ms XHR
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/toggle_obj.js?_=1714415981040

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/js/jquery.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

0d435a55e0d95b4f35fb0d554d59962dda2f768699a96ee416153fe8af42e303

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Accept: text/javascript, application/javascript, application/ecmascript, application/x-ecmascript, */*; q=0.01
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
X-Requested-With: XMLHttpRequest
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000; includeSubDomains
content-security-policy: frame-ancestors 'self'
referrer-policy: no-referrer-when-downgrade
date: Mon, 29 Apr 2024 18:39:42 GMT
last-modified: Thu, 28 Mar 2024 18:37:08 GMT
content-encoding: gzip
etag: "e11f4-176e-614bccf80dd00"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: text/javascript
cache-control: max-age=21363
accept-ranges: bytes
content-length: 1957
x-xss-protection: 1; mode=block
expires: Tue, 30 Apr 2024 00:35:45 GMT

GET
H2 200 icon_rss.gif
www.businesswire.com/images/icons/ 652 B
953 B 114ms
113ms Image
image/gif 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.businesswire.com/images/icons/icon_rss.gif

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

836163f9c71d9ca673fbebdd84ae9061774c673df899e1e49935ab40381f013f

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000; includeSubDomains
content-security-policy: frame-ancestors 'self'
referrer-policy: no-referrer-when-downgrade
date: Mon, 29 Apr 2024 18:39:42 GMT
last-modified: Thu, 28 Mar 2024 18:37:06 GMT
etag: "e05f5-28c-614bccf625880"
x-frame-options: SAMEORIGIN
content-type: image/gif
cache-control: max-age=24104
accept-ranges: bytes
content-length: 652
x-xss-protection: 1; mode=block
expires: Tue, 30 Apr 2024 01:21:26 GMT

GET
H2 200 gtm.js Show response
www.googletagmanager.com/ 313 KB
96 KB 417ms
82ms Script
application/javascript 2a00:1450:4001:806::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtm.js?id=GTM-T4KGVRR

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

0601a07652dacf65a2f9389b64457a10c7b2bc27ef8ca7c12ffb74677fc33096

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:42 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 97897
x-xss-protection: 0
last-modified: Mon, 29 Apr 2024 18:00:00 GMT
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
expires: Mon, 29 Apr 2024 18:39:42 GMT

GET
H2 200 twitter-text.js Show response
www.businesswire.com/js/ 61 KB
20 KB 101ms
101ms Script
text/javascript 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/js/twitter-text.js

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/js/one_trust/scripttemplates/6.4.0/otBannerSdk.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

1802ff7f9181b822cd2adbe838235c8ca736cd99da8ccad0fcf2afe952960d9c

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000; includeSubDomains
content-security-policy: frame-ancestors 'self'
referrer-policy: no-referrer-when-downgrade
date: Mon, 29 Apr 2024 18:39:42 GMT
last-modified: Thu, 28 Mar 2024 18:37:08 GMT
content-encoding: gzip
etag: "e1602-f487-614bccf80dd00"
x-frame-options: SAMEORIGIN
vary: Accept-Encoding
content-type: text/javascript
cache-control: max-age=75651
accept-ranges: bytes
content-length: 19736
x-xss-protection: 1; mode=block
expires: Tue, 30 Apr 2024 15:40:33 GMT

GET
DATA 200
OK truncated
/ 817 B
0 Image
image/svg+xml

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: db311174b0e3c340727b63c055cfb5b317808e909503e1bda11cc58af444f12b

Request headers

Accept-Language: de-DE,de;q=0.9;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

Content-Type: image/svg+xml

GET
H3 200 main.js Show response
cdn.openshareweb.com/v2/3d3dde91/ 149 KB
40 KB 118ms
61ms Script
application/javascript 172.67.74.24
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.openshareweb.com/v2/3d3dde91/main.js
Requested by: Host: cdn.shareaholic.net
URL: https://cdn.shareaholic.net/assets/pub/shareaholic.js
Protocol: H3
Security: QUIC, , AES_128_GCM
Server: 172.67.74.24 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: ecc1baeab33ebd4b540c9de6ec3aefd86d82196db0aacb1b88eac282585afe97

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:42 GMT
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 1748829
alt-svc: h3=":443"; ma=86400
last-modified: Fri, 26 Jan 2024 16:19:53 GMT
server: cloudflare
etag: W/"5a3474c5830f2f6f280c3080e79b7d92"
x-shr-hello-human: This website grows faster with Shareaholic.
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=J5Bz8wTUAqNi615VvwaJ9GLYVpXnOg1cSO1s3G%2BX%2F4ttQMVwUqgDE2jzYrswRFIecTR%2BlZmpSVuRgyDLQy8R9gQ30h9aZRjioV%2FGU2Q9dl69m8xeDAxo%2FV2lVDckuAIhUe8Vz4Ly"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: max-age=31536000, public
vary: Accept-Encoding
x-shr-origin: S3
cf-ray: 87c16a92d8dfbbfd-FRA

POST
H2 200 e
analytics.shareaholic.com/ 43 B
384 B 384ms
118ms Ping
image/gif 3.218.230.104
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL

https://analytics.shareaholic.com/e

Requested by

Host: cdn.openshareweb.com
URL: https://cdn.openshareweb.com/v2/3d3dde91/main.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

3.218.230.104 Ashburn, United States, ASN14618 (AMAZON-AES, US),

Reverse DNS

ec2-3-218-230-104.compute-1.amazonaws.com

Software

Resource Hash

a065920df8cc4016d67c3a464be90099c9d28ffe7c9e6ee3a18f257efc58cbd7

Security Headers

Name	Value
Content-Security-Policy	referrer always

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-platform: "Win32"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: application/x-www-form-urlencoded

Response headers

pragma: no-cache
date: Mon, 29 Apr 2024 18:39:43 GMT
content-security-policy: referrer always
vary: Origin
content-type: image/gif
access-control-allow-origin: https://www.businesswire.com
p3p: CP="OTI DSP COR DEVo ADMa OUR CONo IND COM INT ONL PUR STA OTC"
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
referer-policy: unsafe-url
content-length: 43
expires: Thu, 01 Jan 1970 00:00:00 GMT

GET
H2 200 89dc665dcdfc14f93d0bc528f366fe24.json Show response
www.shareaholic.net/config/ 4 KB
2 KB 378ms
117ms XHR
application/json 184.73.100.94
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://www.shareaholic.net/config/89dc665dcdfc14f93d0bc528f366fe24.json
Requested by: Host: www.businesswire.com
URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 184.73.100.94 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-184-73-100-94.compute-1.amazonaws.com
Software: nginx /
Resource Hash: b7e9eb7ab9e846c2308aaf7ee53765064d1b404b5f61b5ff496b6ab2b9030e26

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-client-geo-country: DE,Deutschland
date: Sun, 28 Apr 2024 22:31:10 GMT
content-encoding: gzip
via: 1.1 varnish (Varnish/6.0)
x-client-geo-metrocode
content-length: 1251
x-client-geo-region
last-modified: Wed, 21 Feb 2024 17:35:13 GMT
server: nginx
vary: Accept-Encoding
access-control-allow-methods: GET, HEAD
x-varnish: 660280397 643875234
content-type: application/json
access-control-allow-origin: *
access-control-expose-headers: Etag, Access-Control-Allow-Origin, x-client-geo-latlong, x-client-geo-country, x-client-geo-city, x-client-geo-zip, x-client-geo-region, x-client-geo-metrocode
cache-control: max-age=3, public, must-revalidate
x-client-geo-city
x-client-geo-zip
access-control-max-age: 2000
accept-ranges: bytes
access-control-allow-headers: *
x-client-geo-latlong: 51.299300,9.491000

GET
H2 200 js Show response
www.googletagmanager.com/gtag/ 302 KB
101 KB 76ms
75ms Script
application/javascript 2a00:1450:4001:806::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=G-ZQWF70T3FK&l=dataLayer&cx=c

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-T4KGVRR

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

d23ddcf075ad66463715b21779e4bafc3fae628d59a7c0a2bba544dc8f6b583b

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
access-control-allow-headers: Cache-Control
content-length: 103284
x-xss-protection: 0
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires: Mon, 29 Apr 2024 18:39:43 GMT

GET
H2 200 3475422.js Show response
js.hs-scripts.com/ 3 KB
1 KB 184ms
85ms Script
application/javascript 2606:4700::6810:89d1
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://js.hs-scripts.com/3475422.js

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-T4KGVRR

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:89d1 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

411636f8e87c2b99fca8cd1669053da0e2d0fb555c504464fc3e47034169e87a

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
content-encoding: br
x-content-type-options: nosniff
cf-cache-status: HIT
x-hubspot-correlation-id: 1a91d675-2ea5-443f-9a6b-1c38d74fb003
x-evy-trace-route-service-name: envoyset-translator
cf-polished: origSize=2961
age: 76
x-envoy-upstream-service-time: 25
x-evy-trace-route-configuration: listener_https/all
x-evy-trace-listener: listener_https
x-request-id: 1a91d675-2ea5-443f-9a6b-1c38d74fb003
cf-bgj: minify
last-modified: Mon, 29 Apr 2024 18:38:27 GMT
server: cloudflare
access-control-max-age: 3600
vary: origin, Accept-Encoding
content-type: application/javascript;charset=utf-8
access-control-allow-origin: https://www.businesswire.com
x-evy-trace-served-by-pod: iad02/hubapi-td/envoy-proxy-5d47c8d44f-btcjv
x-evy-trace-virtual-host: all
access-control-allow-credentials: true
cache-control: public, max-age=90
cf-ray: 87c16a96487c9a3f-FRA
expires: Mon, 29 Apr 2024 18:41:13 GMT

GET
H3 200 buttons.js Show response
cdn.openshareweb.com/v2/3d3dde91/ 182 KB
38 KB 61ms
61ms Script
application/javascript 172.67.74.24
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.openshareweb.com/v2/3d3dde91/buttons.js
Requested by: Host: cdn.shareaholic.net
URL: https://cdn.shareaholic.net/assets/pub/shareaholic.js
Protocol: H3
Security: QUIC, , AES_128_GCM
Server: 172.67.74.24 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: ae3a6a50f0dbc7a564a5e49692c87fcd7049e1d423a94abb8f0dae34d2ceb016

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 1748829
alt-svc: h3=":443"; ma=86400
last-modified: Fri, 26 Jan 2024 16:19:53 GMT
server: cloudflare
etag: W/"5e183c104677d61b6c3e84bbf485f98a"
x-shr-hello-human: This website grows faster with Shareaholic.
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=h1IswUgcnDgfMgmfxo4dCehZhZDYC9d%2FnxsYGDsms9uS1KRsdiq2vSxOuO1TFgoHJTOM0CoQu8FzAyOIk9r2%2Fc%2FapQP9PLenRWrGgM55XdrNvBihDN%2F74twh3PHk%2FLcVD6d77hv8"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: max-age=31536000, public
vary: Accept-Encoding
x-shr-origin: S3
cf-ray: 87c16a965f42bbfd-FRA

GET
H2 200 3475422.js Show response
js.hs-banner.com/ 70 KB
17 KB 158ms
61ms Script
text/javascript 2606:4700:4400::6812:22e5
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://js.hs-banner.com/3475422.js
Requested by: Host: js.hs-scripts.com
URL: https://js.hs-scripts.com/3475422.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:4400::6812:22e5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 9efc19d11aa8b714245e3f3c5e3987422b5c0658dfd85f30dc4cb2f5abd71a25

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
x-amz-version-id: kwOmKM1hCIp6zVr4uL61O9VGuu5lUT9S
content-encoding: br
cf-cache-status: HIT
x-amz-request-id: 57WQRPWT93M5BZNH
x-evy-trace-route-service-name: envoyset-translator
x-amz-server-side-encryption: AES256
x-hubspot-correlation-id: a4514952-4a49-4a99-9123-cff05c0f6383
age: 73
x-envoy-upstream-service-time: 50
x-amz-id-2: /LUXH92hYOd0QsJqffbsK6WW1dcYt4P8RocKA6SJdUiyd4O6HY1GVnv3a96Duu/N+JmdqsP80mc=
x-evy-trace-listener: listener_https
x-request-id: a4514952-4a49-4a99-9123-cff05c0f6383
x-evy-trace-route-configuration: listener_https/all
last-modified: Fri, 29 Mar 2024 16:23:40 GMT
server: cloudflare
etag: W/"7a9f1ff053ef2ea29f78ab2b6824acd6"
access-control-max-age: 604800
access-control-allow-methods: GET, OPTIONS, PUT, POST, DELETE, PATCH, HEAD
content-type: text/javascript; charset=UTF-8
access-control-allow-origin: https://go.businesswire.com
x-evy-trace-virtual-host: all
access-control-expose-headers: x-last-modified-timestamp, X-HubSpot-NotFound, X-HS-User-Request, Link, Server-Timing
cache-control: max-age=300,public
access-control-allow-credentials: true
x-evy-trace-served-by-pod: iad02/analytics-js-proxy-td/envoy-proxy-6dfb9475dd-r2qwz
vary: origin, Accept-Encoding
timing-allow-origin: *
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Accept-Charset, Accept-Encoding, X-Override-Internal-Permissions, X-Properties-Source, X-Properties-SourceId, X-Properties-Flag, X-Hubspot-User-Id, X-Hubspot-Trace, X-Hubspot-Callee, X-Hubspot-Offset, X-Hubspot-No-Trace, X-HubSpot-Static-App-Info, X-HubSpot-Messages-Uri, X-HubSpot-Request-Source, X-HubSpot-Request-Reason, Subscription-Billing-Auth-Token, X-App-CSRF, X-Tools-CSRF, Online-Payment-Signing-UUID, X-Source, X-SourceId, X-Origin-UserId, X-Biden-Request-Source, X-HubSpot-CSRF-hubspotapi, X-Force-Cookie-Refresh, X-Force-Cookie-Refresh-No-Cache, X-HS-User-Request, X-Application-Id, X-HS-Referer, X-HubSpot-Correlation-Id
cf-ray: 87c16a977b4f3a73-FRA
expires: Mon, 29 Apr 2024 18:43:30 GMT

GET
H2 200 3475422.js Show response
js.hs-analytics.net/analytics/1714415700000/ 67 KB
21 KB 156ms
59ms Script
text/javascript 2606:4700::6811:afc9
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://js.hs-analytics.net/analytics/1714415700000/3475422.js
Requested by: Host: js.hs-scripts.com
URL: https://js.hs-scripts.com/3475422.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6811:afc9 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 2ff5e827b56c30d1efe166b690ef242d49cb60e2431af7d273a00486931d40ca

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
x-amz-version-id: null
content-encoding: br
cf-cache-status: HIT
x-amz-request-id: TB4K566GK3TMQ1F4
x-evy-trace-route-service-name: envoyset-translator
x-amz-server-side-encryption: AES256
x-hubspot-correlation-id: 16c69d3e-8985-4cb2-90a6-ae662f7e5c6e
age: 280
x-envoy-upstream-service-time: 62
x-amz-id-2: mGmlnzZxNitgz35CDw0ZCAkAyK/NTs9WUD3n3mwhyUAIp6mKwsa9sXFsITb4dG9RPt9cPa/Pu28=
x-evy-trace-listener: listener_https
x-request-id: 16c69d3e-8985-4cb2-90a6-ae662f7e5c6e
x-evy-trace-route-configuration: listener_https/all
last-modified: Wed, 24 Apr 2024 18:16:16 GMT
server: cloudflare
etag: W/"c0d9ef06e0b3d93abc6fa9adeae2da38"
vary: origin, Accept-Encoding
content-type: text/javascript
x-evy-trace-virtual-host: all
x-evy-trace-served-by-pod: iad02/analytics-js-proxy-td/envoy-proxy-78cb6f459b-8vwdw
cache-control: max-age=300,public
access-control-allow-credentials: false
cf-ray: 87c16a977c674daa-FRA
expires: Mon, 29 Apr 2024 18:40:03 GMT

GET
H2 200 leadflows.js Show response
js.hsleadflows.net/ 551 KB
88 KB 159ms
56ms Script
application/javascript 2606:4700::6812:8d11
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://js.hsleadflows.net/leadflows.js

Requested by

Host: js.hs-scripts.com
URL: https://js.hs-scripts.com/3475422.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:8d11 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

efb5dc6835aeb8a8e1615ca49df1828cfaf708dc73651c5f1c651f2d2ab3907a

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Origin: https://www.businesswire.com
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

content-encoding: br
age: 32076
x-evy-trace-route-service-name: envoyset-translator
x-amz-server-side-encryption: AES256
content-security-policy-report-only: frame-ancestors 'self'; report-uri https://send.hsbrowserreports.com/csp/report?resource=lead-flows-js/static-1.1338/bundle/main/lead-flows-release.js&cfRay=87be5b7f7bb15d90-FRA
x-amz-replication-status: COMPLETED
x-evy-trace-listener: listener_https
etag: W/"d252299cef5b9176cf0435e72e0baeeb"
vary: Accept-Encoding,Origin,Access-Control-Request-Headers,Access-Control-Request-Method
access-control-allow-methods: GET
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
x-evy-trace-virtual-host: all
cache-control: s-maxage=86400, max-age=0
x-hs-target-asset: lead-flows-js/static-1.1338/bundle/main/lead-flows-release.js
date: Mon, 29 Apr 2024 18:39:43 GMT
x-amz-version-id: FzXUOelq5PzvbDhLOc3Au0ThiCBuXHAc
via: 1.1 66b6cd04ec22251498906e833eb08668.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: HIT
x-amz-cf-pop: IAD12-P3
x-hubspot-correlation-id: 1035007a-a3bc-4375-843c-3a4ea4fc93de
x-cache: Hit from cloudfront
cache-tag: staticjsapp-lead-flows-cloudflare-web-prod,staticjsapp-prod
x-envoy-upstream-service-time: 9
x-evy-trace-route-configuration: listener_https/all
x-request-id: 1035007a-a3bc-4375-843c-3a4ea4fc93de
last-modified: Wed, 03 Apr 2024 09:27:53 UTC
server: cloudflare
access-control-max-age: 3000
x-hs-cache-status: MISS
x-evy-trace-served-by-pod: iad02/app-td/envoy-proxy-68b7f7fbff-trtck
cf-ray: 87c16a9778d7a037-FRA
x-amz-cf-id: cSBjxTKMnwggPpR7-iJ2TAsv7p3U5Z6heHG4_DQljK2EU5x6F-nGHw==

GET
H2 200 web-interactives-embed.js Show response
js.hubspot.com/ 82 KB
25 KB 165ms
71ms Script
application/javascript 2606:4700::6810:7674
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://js.hubspot.com/web-interactives-embed.js

Requested by

Host: js.hs-scripts.com
URL: https://js.hs-scripts.com/3475422.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:7674 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e8903e555bd60b3e66725a7316fa1c399c1c330b6f207dfbf294e287857d526c

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Origin: https://www.businesswire.com
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

content-encoding: br
age: 591
x-evy-trace-route-service-name: envoyset-translator
x-amz-server-side-encryption: AES256
content-security-policy-report-only: frame-ancestors 'self'; report-uri https://send.hsbrowserreports.com/csp/report?resource=web-interactives-embed/static-2.1087/bundles/project.js&cfRay=87c15c2aba953aa2-FRA
x-amz-replication-status: COMPLETED
x-evy-trace-listener: listener_https
etag: W/"aca27b624bf30d36e5f4f145ae76704a"
vary: Accept-Encoding
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
x-evy-trace-virtual-host: all
cache-control: max-age=600
x-hs-target-asset: web-interactives-embed/static-2.1087/bundles/project.js
date: Mon, 29 Apr 2024 18:39:43 GMT
x-amz-version-id: iqAR5gkkMAkFd.Z3L05RGWJk1d1nl__E
via: 1.1 d0d53eedec01ac540f737b5fafb16436.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-amz-cf-pop: IAD12-P3
x-hubspot-correlation-id: ae9f0558-e3b0-4195-beaa-d7ac1efcd2f9
x-cache: Hit from cloudfront
cache-tag: staticjsapp-web-interactives-embed-web-prod,staticjsapp-prod
x-envoy-upstream-service-time: 1
x-evy-trace-route-configuration: listener_https/all
x-request-id: ae9f0558-e3b0-4195-beaa-d7ac1efcd2f9
last-modified: Fri, 26 Apr 2024 11:14:32 UTC
server: cloudflare
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=LAZ068T%2BH6ppfb0i10VSakEem2ViYRIodWZDjw%2FEmSDGYuf0y4rxsfb9%2Bxh32AQShXd4FSLVkdUMPRwXFEdu4K5eZQnMVyjOw0ubY231SEm88xNk7sF8P%2BLm5npcBbftjvv6JfeMn9eXe3PD"}],"group":"cf-nel","max_age":604800}
x-hs-cache-status: HIT
x-evy-trace-served-by-pod: iad02/app-td/envoy-proxy-68b7f7fbff-6q8hm
cf-ray: 87c16a976d993664-FRA
x-amz-cf-id: 6wVoPA065_WizIruDYxY9BqTHJZRqKTj1Xm1NHbNPOK6jowncXO3iQ==

GET
H2 200 fb.js Show response
js.hsadspixel.net/ 6 KB
4 KB 171ms
72ms Script
application/javascript 2606:4700::6811:80ac
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://js.hsadspixel.net/fb.js

Requested by

Host: js.hs-scripts.com
URL: https://js.hs-scripts.com/3475422.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6811:80ac , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

1c67d8ce90160a6586cfd2c2a936959738f5b1843ebdfbac4325c4d1a9b61224

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
x-amz-version-id: H75lIw.llLd5LbqLQfJpi4qQ6NOhCtlN
via: 1.1 2a3aa853116c0a37d6c7762eca54d208.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: HIT
x-amz-cf-pop: IAD12-P3
age: 301
x-amz-server-side-encryption: AES256
x-evy-trace-route-service-name: envoyset-translator
content-security-policy-report-only: frame-ancestors 'self'; report-uri https://send.hsbrowserreports.com/csp/report?resource=adsscriptloaderstatic/static-1.551/bundles/pixels-release.js&cfRay=87c1633cd93a2c3a-FRA
x-cache: Hit from cloudfront
x-hubspot-correlation-id: 6d8298fc-d399-492d-ab4f-6d69c0dd1823
cache-tag: staticjsapp-AdsScriptLoaderCloudflare-web-prod,staticjsapp-prod
content-encoding: br
x-envoy-upstream-service-time: 0
x-amz-replication-status: COMPLETED
x-evy-trace-route-configuration: listener_https/all
x-evy-trace-listener: listener_https
x-request-id: 6d8298fc-d399-492d-ab4f-6d69c0dd1823
last-modified: Fri, 19 Apr 2024 14:01:51 UTC
server: cloudflare
etag: W/"65a4cdf8f8c613ea8f766101eea8e667"
vary: Accept-Encoding
content-type: application/javascript; charset=utf-8
x-hs-cache-status: HIT
x-evy-trace-virtual-host: all
cache-control: max-age=600
x-evy-trace-served-by-pod: iad02/app-td/envoy-proxy-68b7f7fbff-5ssq8
cf-ray: 87c16a9778f0a5f9-FRA
x-amz-cf-id: _EX_s0zbI8bGXbt1pnObSqaF-AHbkrpAGuOQu2sIYB3gImUp0C0L4w==
x-hs-target-asset: adsscriptloaderstatic/static-1.551/bundles/pixels-release.js

GET
H2 200 conversations-embed.js Show response
js.usemessages.com/ 85 KB
25 KB 153ms
54ms Script
application/javascript 2606:4700::6810:4c8e
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://js.usemessages.com/conversations-embed.js

Requested by

Host: js.hs-scripts.com
URL: https://js.hs-scripts.com/3475422.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:4c8e , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

156b381819247eb013bfd7ad6cd96fed291f0a1bfb55206c8e644bb42576c5c7

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
x-amz-version-id: GvgLK8fwBknh5qjmyScH5OBLxCldU5fy
via: 1.1 c3d335addde48969fafe25d4064cee80.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: HIT
x-amz-cf-pop: IAD12-P3
age: 71
x-amz-server-side-encryption: AES256
x-evy-trace-route-service-name: envoyset-translator
content-security-policy-report-only: frame-ancestors 'self'; report-uri https://send.hsbrowserreports.com/csp/report?resource=conversations-embed/static-1.16164/bundles/project.js&cfRay=87c168da6b9c9018-FRA
x-cache: Hit from cloudfront
x-hubspot-correlation-id: b03180e9-3d49-4c58-b8d9-b2e8f2e69c69
cache-tag: staticjsapp-conversations-embed-web-prod,staticjsapp-prod
content-encoding: br
x-envoy-upstream-service-time: 8
x-amz-replication-status: COMPLETED
x-evy-trace-route-configuration: listener_https/all
x-evy-trace-listener: listener_https
x-request-id: b03180e9-3d49-4c58-b8d9-b2e8f2e69c69
last-modified: Thu, 25 Apr 2024 15:01:14 UTC
server: cloudflare
etag: W/"62f54fd24c76f93ed036543b6c349661"
vary: Accept-Encoding
content-type: application/javascript; charset=utf-8
x-hs-cache-status: MISS
x-evy-trace-virtual-host: all
cache-control: max-age=600
x-evy-trace-served-by-pod: iad02/app-td/envoy-proxy-68b7f7fbff-xzfkt
cf-ray: 87c16a977ac09763-FRA
x-amz-cf-id: -ZWvQwGOaemV41gDTzqLJe-qwaa68xA9tvOFEYNbTcpo8Ob4hv4dcQ==
x-hs-target-asset: conversations-embed/static-1.16164/bundles/project.js

GET
H3 200 shareaholic-icons.woff2
cdn.openshareweb.com/v2/fonts_72e7af4e/ 16 KB
16 KB 151ms
107ms Font
font/woff2 172.67.74.24
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.openshareweb.com/v2/fonts_72e7af4e/shareaholic-icons.woff2
Requested by: Host: www.businesswire.com
URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Protocol: H3
Security: QUIC, , AES_128_GCM
Server: 172.67.74.24 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 468b6d8345a1430df2386c8d02e0809ef90b5d49fcd08adb465464b2df4f1325

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/
Origin: https://www.businesswire.com
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 1748502
alt-svc: h3=":443"; ma=86400
last-modified: Fri, 01 Dec 2023 19:15:00 GMT
server: cloudflare
etag: W/"c49248b292699883eb79e36ddcd13a63"
vary: Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
access-control-max-age: 2000
access-control-allow-methods: GET, HEAD, PUT, POST, DELETE
content-type: font/woff2
access-control-allow-origin: *
access-control-expose-headers: ETag, Access-Control-Allow-Origin
cache-control: max-age=31536000, public
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=MF%2Bkjq0mN00xD%2FE4eMg7%2FIYWiD15wQxoawuf4ApkyKt7w0CfCORiGlsCr4Znkk2bNBKioD4Mih1aEHWlwAGuKtLTpGrWQwc8L0GHTx8iacw16v6b6rsackdkWdRhTt4I6awamkbq"}],"group":"cf-nel","max_age":604800}
x-shr-hello-human: This website grows faster with Shareaholic.
x-shr-origin: S3
cf-ray: 87c16a978a761c28-FRA

GET
DATA 200
OK truncated
/ 492 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 4299f2aaa46eea61cff7da0f945e26cf0ace8a35ea912182e7df2a9958db8e10

Request headers

Accept-Language: de-DE,de;q=0.9;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

Content-Type: image/png

GET
H2 200 public Show response
api.hubspot.com/livechat-public/v1/message/ 399 B
1 KB 178ms
177ms XHR
application/json 2606:4700::6810:7674
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://api.hubspot.com/livechat-public/v1/message/public?portalId=3475422&conversations-embed=static-1.16164&mobile=false&messagesUtk=3b39b385f5954a49a082d7ea83fccc27&traceId=3b39b385f5954a49a082d7ea83fccc27

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:7674 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

88d29078e02813b4d7e17ee4d9cd8477516b4c750160f2f1b7d85790c5c09ac8

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
X-HubSpot-Messages-Uri: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-evy-trace-route-service-name: envoyset-translator
x-hubspot-correlation-id: b2712b36-c2a8-4628-9332-75db516712fc
x-envoy-upstream-service-time: 8
content-length: 310
x-evy-trace-route-configuration: listener_https/all
x-evy-trace-listener: listener_https
x-request-id: b2712b36-c2a8-4628-9332-75db516712fc
server: cloudflare
vary: origin, Accept-Encoding
access-control-allow-methods: GET, OPTIONS, PUT, POST, DELETE, PATCH, HEAD
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.businesswire.com
x-evy-trace-served-by-pod: iad02/hubapi-td/envoy-proxy-5d47c8d44f-f6b5c
cache-control: no-cache, no-store, no-transform, must-revalidate, max-age=0
access-control-allow-credentials: false
x-evy-trace-virtual-host: all
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=mO6ZZ9DuikAXH47v1x%2Ffdudvl6h7MqUhLV5N9yBYVVKWt%2B%2FM0fWsI6yZmzqXChCe4Ni6%2FiNG3hSklCUSchftLbw2KfRIqD3ZedkJolRai5q%2F6YDYpu34Fe8ofG9q1nKfziUdfxal17XU%2B8mI%2Bw%3D%3D"}],"group":"cf-nel","max_age":604800}
cf-ray: 87c16a9918663664-FRA
access-control-allow-headers: Accept, Accept-Charset, Accept-Encoding, Accept-Language, Content-Type, Host, Origin, Referer, User-Agent, X-HubSpot-Messages-Uri

GET
H2 200 combinedConfigs Show response
cta-service-cms2.hubspot.com/web-interactives/public/v1/embed/ 433 B
1 KB 199ms
189ms Fetch
application/json 2606:4700::6810:7674
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cta-service-cms2.hubspot.com/web-interactives/public/v1/embed/combinedConfigs?portalId=3475422&currentUrl=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production

Requested by

Host: js.hubspot.com
URL: https://js.hubspot.com/web-interactives-embed.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:7674 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

b4bf8910a202b24bd61be26e28eaa8c5f83a48d78999b2693a9cbdf4c9910cf1

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-evy-trace-route-service-name: envoyset-translator
x-hubspot-correlation-id: d4e871ce-4cc7-45b6-9b01-af81373ce01d
content-encoding: br
x-envoy-upstream-service-time: 19
x-evy-trace-route-configuration: listener_https/all
x-evy-trace-listener: listener_https
x-request-id: d4e871ce-4cc7-45b6-9b01-af81373ce01d
server: cloudflare
vary: origin
access-control-allow-methods: OPTIONS, GET
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.businesswire.com
x-evy-trace-virtual-host: all
access-control-max-age: 180
access-control-allow-credentials: true
cache-control: max-age=0, no-cache, no-store
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=Gm79OJWDWEA7jA138HIw18x9yO%2FU38WM9tYkIaIkj%2FZJPSxvChBovS6TYCG3L9TWbMZhFRbIacdPaW8tqfOXKVs1S0zPnr%2BQcRzXTUQ2mRmnPgMtMQ08Nztdl3wUpGC9Ag9P1M33LoNXwHPN1tgpJ4Unt9mf8%2FOZPx0%3D"}],"group":"cf-nel","max_age":604800}
x-robots-tag: noindex, follow
access-control-allow-headers: Accept, Accept-Charset, Accept-Encoding, Accept-Language, Content-Type, Host, Origin, Referer, User-Agent
cf-ray: 87c16a981ec23664-FRA
x-evy-trace-served-by-pod: iad02/star-hubspot-td/envoy-proxy-9fd6b4b-844hl

GET
H2 200 json Show response
api.hubapi.com/hs-script-loader-public/v1/config/pixels-and-events/ 179 B
1 KB 393ms
173ms XHR
application/json 2606:4700::6812:f46c
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://api.hubapi.com/hs-script-loader-public/v1/config/pixels-and-events/json?portalId=3475422

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:f46c , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

f5fa15f0179cb863d0390487b7cbb5b57a0bdfbdb7a7178045afb8ee3abe37bc

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-evy-trace-route-service-name: envoyset-translator
x-hubspot-correlation-id: d1b23238-f916-4f41-b5c1-f38f65f181c9
content-encoding: br
x-envoy-upstream-service-time: 4
x-evy-trace-route-configuration: listener_https/all
x-evy-trace-listener: listener_https
x-request-id: d1b23238-f916-4f41-b5c1-f38f65f181c9
server: cloudflare
vary: origin, Accept-Encoding
access-control-allow-methods: GET, OPTIONS, PUT, POST, DELETE, PATCH, HEAD
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.businesswire.com
x-evy-trace-served-by-pod: iad02/hubapi-td/envoy-proxy-5d47c8d44f-fpdfw
access-control-max-age: 180
access-control-allow-credentials: false
x-evy-trace-virtual-host: all
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=uGJWjgfNSuwzFLwTwyBODWKjQc8%2BUIP8KlIkL4olQwP9RC5O1eaw85q5hvZe0Cia69RxOudatwWa1ttczzMf7EhGiVIXur4FLofe%2BXF4IpGddssB2eobXS%2B8LcJofwxaogtan8i4EELHpdsL"}],"group":"cf-nel","max_age":604800}
cf-ray: 87c16a997805917c-FRA
access-control-allow-headers: *

OPTIONS
H2 200 public
api.hubspot.com/livechat-public/v1/message/ 0
0 183ms
173ms Preflight
text/plain 2606:4700::6810:7674
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:7674 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Accept: */*
Access-Control-Request-Headers: x-hubspot-messages-uri
Access-Control-Request-Method: GET
Origin: https://www.businesswire.com
Sec-Fetch-Mode: cors
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

access-control-allow-credentials: false
access-control-allow-headers: Accept, Accept-Charset, Accept-Encoding, Accept-Language, Content-Type, Host, Origin, Referer, User-Agent, X-HubSpot-Messages-Uri
access-control-allow-methods: GET, OPTIONS, PUT, POST, DELETE, PATCH, HEAD
access-control-allow-origin: https://www.businesswire.com
allow: HEAD,GET,OPTIONS
cf-cache-status: DYNAMIC
cf-ray: 87c16a97fe773664-FRA
content-length: 18
content-type: text/plain; charset=utf-8
date: Mon, 29 Apr 2024 18:39:43 GMT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=BiE0na6UAOo6Qcpq8jrfK%2Fj85Gh9RBBLwdoTpqxzzvdWkDBm804UyI9WWDDXAexHwX8uA83gs51QClDAbyIXF4arrSmR990lHK0UPweX%2BNyths1spZAwUVocCfBCfKgLM7O18nuiSQCulBC6%2Bg%3D%3D"}],"group":"cf-nel","max_age":604800}
server: cloudflare
strict-transport-security: max-age=31536000; includeSubDomains; preload
vary: origin, Accept-Encoding
x-content-type-options: nosniff
x-envoy-upstream-service-time: 2
x-evy-trace-listener: listener_https
x-evy-trace-route-configuration: listener_https/all
x-evy-trace-route-service-name: envoyset-translator
x-evy-trace-served-by-pod: iad02/hubapi-td/envoy-proxy-5d47c8d44f-v52ph
x-evy-trace-virtual-host: all
x-hubspot-correlation-id: 886bbbbd-7f75-4138-b015-94a0e2bd1045
x-request-id: 886bbbbd-7f75-4138-b015-94a0e2bd1045

POST
H2 204 collect
region1.analytics.google.com/g/ 0
249 B 189ms
45ms Ping
text/plain 2001:4860:4802:34::36
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://region1.analytics.google.com/g/collect?v=2&tid=G-ZQWF70T3FK&gtm=45je44o0v890388055z8832779862za200&_p=1714415982424&_gaz=1&gcd=13l3l3l2l1&npa=1&dma_cps=sypham&dma=1&cid=594054144.1714415983&ul=de-de&sr=1600x1200&uaa=x86&uab=64&uafvl=Chromium%3B124.0.6367.78%7CGoogle%2520Chrome%3B124.0.6367.78%7CNot-A.Brand%3B99.0.0.0&uamb=0&uam=&uap=Win32&uapv=10.0.0&uaw=0&pscdl=noapi&_s=1&sid=1714415983&sct=1&seg=0&dl=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production&dt=TriLink%20BioTechnologies%C2%AE%20Announces%20New%20San%20Diego%20Facility%20for%20Late%20Phase%20mRNA%20Drug%20Substance%20Production%20%7C%20Business%20Wire&en=page_view&_fv=1&_nsi=1&_ss=1&tfd=4131
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-ZQWF70T3FK&l=dataLayer&cx=c
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2001:4860:4802:34::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software: Golfe2 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

pragma: no-cache
date: Mon, 29 Apr 2024 18:39:43 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://www.businesswire.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

POST
H2 204 collect
stats.g.doubleclick.net/g/ 0
258 B 191ms
47ms Ping
text/plain 2a00:1450:400c:c02::9d
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://stats.g.doubleclick.net/g/collect?v=2&tid=G-ZQWF70T3FK&cid=594054144.1714415983&gtm=45je44o0v890388055z8832779862za200&aip=1&dma=1&dma_cps=sypham&gcd=13l3l3l2l1&npa=1
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-ZQWF70T3FK&l=dataLayer&cx=c
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a00:1450:400c:c02::9d Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software: Golfe2 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

pragma: no-cache
date: Mon, 29 Apr 2024 18:39:43 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://www.businesswire.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H3 200 ga-audiences
www.google.de/ads/ 42 B
63 B 208ms
66ms Image
image/gif 216.58.206.67
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.de/ads/ga-audiences?v=1&t=sr&slf_rd=1&_r=4&tid=G-ZQWF70T3FK&cid=594054144.1714415983&gtm=45je44o0v890388055z8832779862za200&aip=1&dma=1&dma_cps=sypham&gcd=13l3l3l2l1&npa=1&z=2008801912

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

216.58.206.67 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

tzfraa-aa-in-f3.1e100.net

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

pragma: no-cache
date: Mon, 29 Apr 2024 18:39:43 GMT
x-content-type-options: nosniff
server: cafe
content-type: image/gif
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control: no-cache, no-store, must-revalidate
cross-origin-resource-policy: cross-origin
timing-allow-origin: *
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H3 200 counters.gif
perf-na1.hsforms.com/embed/v3/ 35 B
926 B 255ms
187ms Image
image/gif 104.19.175.188
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://perf-na1.hsforms.com/embed/v3/counters.gif?key=config-loaded-success&value=1

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

104.19.175.188 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: MISS
x-evy-trace-route-service-name: envoyset-translator
x-hubspot-correlation-id: a07072de-6454-44bc-812f-80d8d390fcc9
x-envoy-upstream-service-time: 6
alt-svc: h3=":443"; ma=86400
content-length: 35
x-evy-trace-route-configuration: listener_https/all
x-evy-trace-listener: listener_https
x-request-id: a07072de-6454-44bc-812f-80d8d390fcc9
last-modified: Mon, 29 Apr 2024 18:39:43 GMT
server: cloudflare
vary: origin, Accept-Encoding
content-type: image/gif
x-evy-trace-virtual-host: all
x-evy-trace-served-by-pod: iad02/star-hubspot-td/envoy-proxy-9fd6b4b-nlt68
access-control-expose-headers: X-Origin-Hublet
cache-control: max-age=0, no-cache, no-store
access-control-allow-credentials: false
accept-ranges: bytes
x-robots-tag: none
cf-ray: 87c16a99ce5dbfc3-WAW

GET
H3 200 js Show response
www.googletagmanager.com/gtag/ 247 KB
85 KB 66ms
66ms Script
application/javascript 172.217.16.200
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=AW-1054961044

Requested by

Host: js.hsadspixel.net
URL: https://js.hsadspixel.net/fb.js

Protocol

Security

QUIC, , AES_128_GCM

Server

172.217.16.200 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s65-in-f8.1e100.net

Software

Google Tag Manager /

Resource Hash

bec91d8c9b18364bbe37aff4b197046100ece7561a61bf6adbf1a91e90500c8c

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 87415
x-xss-protection: 0
last-modified: Mon, 29 Apr 2024 18:00:00 GMT
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
expires: Mon, 29 Apr 2024 18:39:43 GMT

GET
H3 200 js Show response
www.googletagmanager.com/gtag/ 247 KB
85 KB 69ms
69ms Script
application/javascript 172.217.16.200
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=AW-1054961044&l=dataLayer&cx=c

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-T4KGVRR

Protocol

Security

QUIC, , AES_128_GCM

Server

172.217.16.200 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s65-in-f8.1e100.net

Software

Google Tag Manager /

Resource Hash

9d283ebcf00931b779bda550bee91c98224b2aea4ae0807783d96a8064dc7d69

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:43 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 87396
x-xss-protection: 0
last-modified: Mon, 29 Apr 2024 18:00:00 GMT
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
expires: Mon, 29 Apr 2024 18:39:43 GMT

GET
H2 200 insight.min.js Show response
snap.licdn.com/li.lms-analytics/ 48 KB
17 KB 134ms
40ms Script
application/javascript 2a02:26f0:3500:16::215:1484
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL

https://snap.licdn.com/li.lms-analytics/insight.min.js

Requested by

Host: js.hsadspixel.net
URL: https://js.hsadspixel.net/fb.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:3500:16::215:1484 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),

Reverse DNS

Software

Resource Hash

9941d2ff1cc99d68acf87db2bf00d461644f6a6f222af62c2fba71be5a97b447

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-edgeconnect-origin-mex-latency: 160
date: Mon, 29 Apr 2024 18:39:43 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Mon, 29 Apr 2024 18:02:39 GMT
x-cdn: AKAM
x-edgeconnect-midmile-rtt: 0
x-amz-server-side-encryption: AES256
vary: Accept-Encoding
content-type: application/javascript;charset=utf-8
cache-control: max-age=84198
accept-ranges: bytes
content-length: 17091

GET
H2

200

collect
px4.ads.linkedin.com/
Redirect Chain

https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=23320&time=1714415983890&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-...
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=23320&time=1714415983890&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-...
https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D23320%26time%3D1714415983890%26url%3Dhttps%253A%252F%252Fwww.businesswire.com%252...
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=23320&time=1714415983890&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-...
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=23320&time=1714415983890&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces...

0
482 B

254ms
145ms

Image
application/javascript

13.107.42.14
MICROSOFT-CORP-MS...

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=23320&time=1714415983890&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production&cookiesTest=true&liSync=true&e_ipv6=AQINJ_HS-cunQQAAAY8rJ-HuT9KmGRt5nMzUKSLGdHpFT1bUbA5_mn9WycYoq4ETWnCAtLg
Requested by: Host: www.businesswire.com
URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Protocol: H2
Server: 13.107.42.14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language: de-DE,de;q=0.9;q=0.9
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36

Response headers

date: Mon, 29 Apr 2024 18:39:44 GMT
nel: {"report_to":"network-errors","max_age":1296000,"success_fraction":0.00066,"failure_fraction":1,"include_subdomains":true}
x-li-pop: afd-prod-lva1-x
x-msedge-ref: Ref A: D5481DE393CC46F59BCA8A0ADF271166 Ref B: FRAEDGE1106 Ref C: 2024-04-29T18:39:45Z
linkedin-action: 1
report-to: {"group":"network-errors","max_age":2592000,"endpoints":[{"url":"https://www.linkedin.com/li/rep"}],"include_subdomains":true}
content-type: application/javascript
x-li-fabric: prod-lva1
x-cache: CONFIG_NOCACHE
x-li-proto: http/2
content-length: 0
x-li-uuid: AAYXQJPOXFpZobxMr+FYkQ==

Redirect headers

date: Mon, 29 Apr 2024 18:39:44 GMT
nel: {"report_to":"network-errors","max_age":1296000,"success_fraction":0.00066,"failure_fraction":1,"include_subdomains":true}
x-li-pop: afd-prod-lva1-x
x-msedge-ref: Ref A: 4DE7C5C35D4F4847A5EB0C5F18F8D3CF Ref B: DUS30EDGE0311 Ref C: 2024-04-29T18:39:45Z
linkedin-action: 1
report-to: {"group":"network-errors","max_age":2592000,"endpoints":[{"url":"https://www.linkedin.com/li/rep"}],"include_subdomains":true}
x-li-fabric: prod-lva1
location: https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=23320&time=1714415983890&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production&cookiesTest=true&liSync=true&e_ipv6=AQINJ_HS-cunQQAAAY8rJ-HuT9KmGRt5nMzUKSLGdHpFT1bUbA5_mn9WycYoq4ETWnCAtLg
x-cache: CONFIG_NOCACHE
x-li-proto: http/2
content-length: 0
x-li-uuid: AAYXQJPKaoxVLwCQzOckyw==

POST
H2 204 / Show response
px.ads.linkedin.com/wa/ 0
482 B 174ms
155ms XHR
text/plain 2620:1ec:21::14
MICROSOFT-CORP-MS...

General

Check archive.org

Show headers Download Go to

Full URL: https://px.ads.linkedin.com/wa/
Requested by: Host: www.businesswire.com
URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 2620:1ec:21::14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
Content-Type: text/plain;charset=UTF-8
Accept: *
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:45 GMT
nel: {"report_to":"network-errors","max_age":1296000,"success_fraction":0.00066,"failure_fraction":1,"include_subdomains":true}
x-li-pop: afd-prod-lva1-x
x-msedge-ref: Ref A: BF9140BD31E24FA4963F23E12B5FE1B1 Ref B: DUS30EDGE0311 Ref C: 2024-04-29T18:39:45Z
linkedin-action: 1
vary: Origin
report-to: {"group":"network-errors","max_age":2592000,"endpoints":[{"url":"https://www.linkedin.com/li/rep"}],"include_subdomains":true}
x-li-fabric: prod-lva1
access-control-allow-origin: https://www.businesswire.com
x-cache: CONFIG_NOCACHE
x-li-proto: http/2
access-control-allow-credentials: true
x-li-uuid: AAYXQJPQ/vwehHogifNw9A==

GET
H2 200 nr-1071.min.js Show response
js-agent.newrelic.com/ 23 KB
10 KB 134ms
38ms Script
application/javascript 2602:816:5001::39
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL

https://js-agent.newrelic.com/nr-1071.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2602:816:5001::39 , United States, ASN54113 (FASTLY, US),

Reverse DNS

Software

AmazonS3 /

Resource Hash

56097e8b7ceb27db42a5e102af6d11dfdcaee13d8716477a8e242b4957d7a280

Security Headers

Name	Value
Strict-Transport-Security	max-age=300

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

x-amz-version-id: CMlnzU8oXfDtKpYX3Vbq5JF_lbJX7.9b
content-encoding: br
via: 1.1 varnish
date: Mon, 29 Apr 2024 18:39:45 GMT
strict-transport-security: max-age=300
x-amz-request-id: 30KQX3FVTE9P3TNC
x-amz-server-side-encryption: AES256
x-cache: HIT
cross-origin-resource-policy: cross-origin
content-length: 9494
x-amz-id-2: IvYvQErBXb8NHBCg5NYRt5vt8N0JLkv4HF+aNhzjnsZX6vgWqepNkVE/wyGzSnNo69RkJxgNmVk=
x-served-by: cache-cph2320026-CPH
last-modified: Wed, 18 Oct 2023 20:59:01 GMT
server: AmazonS3
etag: "a1a545c95f313a230157b47dca555c25"
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000, stale-while-revalidate=86400, stale-if-error=86400
accept-ranges: bytes
x-cache-hits: 3048

GET
H2 200 __ptq.gif
track.hubspot.com/ 45 B
1 KB 292ms
197ms Image
image/gif 2606:4700::6810:7674
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://track.hubspot.com/__ptq.gif?k=1&sd=1600x1200&cd=24-bit&cs=UTF-8&ln=de-de&bfp=2492303821&v=1.1&a=3475422&rcu=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production&pu=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production&t=TriLink+BioTechnologies%C2%AE+Announces+New+San+Diego+Facility+for+Late+Phase+mRNA+Drug+Substance+Production+%7C+Business+Wire&cts=1714415985489&vi=647017c5d3545be16452baf791365a4e&nc=true&u=241090844.647017c5d3545be16452baf791365a4e.1714415985481.1714415985481.1714415985481.1&b=241090844.1.1714415985482&cc=15

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:7674 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

dc111a70984a9eda00752b06277113029ef288f1125c31eff2477413e15e8aa4

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:45 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-evy-trace-route-service-name: envoyset-translator
x-hubspot-correlation-id: 580f575e-369a-465a-9f99-098d77ba2eff
p3p: CP="NOI CUR ADM OUR NOR STA NID"
x-envoy-upstream-service-time: 28
content-length: 45
x-evy-trace-route-configuration: listener_https/all
x-evy-trace-listener: listener_https
x-request-id: 580f575e-369a-465a-9f99-098d77ba2eff
server: cloudflare
vary: origin, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=URqIZJj66F8ZzUiUsryNtKA0vwsLGshNXpmhirIi8XLVLLAOV1r1JTuH4JneN2MizZKe18Xw6MhU9zrzrU6w%2FkuWEyo1MHWxmQUbsII73Ieng%2B58A2dpDf5pvzFVDpNsGW57qRGv4u4oyH5cP42p"}],"group":"cf-nel","max_age":604800}
content-type: image/gif
x-evy-trace-served-by-pod: iad02/analytics-tracking-td/envoy-proxy-76d96f8b5d-rk2jf
x-evy-trace-virtual-host: all
cache-control: no-cache, no-store, no-transform
access-control-allow-credentials: false
cf-ray: 87c16aa60aa8040c-FRA
x-robots-tag: none

GET
H2 200 icon_hidden.gif
www.businesswire.com/images/icons/ 111 B
411 B 98ms
98ms Image
image/gif 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.businesswire.com/images/icons/icon_hidden.gif

Requested by

Host: www.businesswire.com
URL: https://www.businesswire.com/css/style.css

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

680ecc4293b4cde94f0cf988231574e5a428670cfdcb267ff10e0237af7975c3

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/css/style.css
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000; includeSubDomains
content-security-policy: frame-ancestors 'self'
referrer-policy: no-referrer-when-downgrade
date: Mon, 29 Apr 2024 18:39:45 GMT
last-modified: Thu, 28 Mar 2024 18:37:06 GMT
etag: "e0564-6f-614bccf625880"
x-frame-options: SAMEORIGIN
content-type: image/gif
cache-control: max-age=71400
accept-ranges: bytes
content-length: 111
x-xss-protection: 1; mode=block
expires: Tue, 30 Apr 2024 14:29:45 GMT

GET
H2 200 json Show response
forms.hubspot.com/lead-flows-config/v1/config/ 178 B
1 KB 240ms
220ms XHR
application/json 2606:4700::6810:7674
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://forms.hubspot.com/lead-flows-config/v1/config/json?portalId=3475422&utk=647017c5d3545be16452baf791365a4e&__hstc=241090844.647017c5d3545be16452baf791365a4e.1714415985481.1714415985481.1714415985481.1&__hssc=241090844.1.1714415985482&currentUrl=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6810:7674 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

9ce62f98ce93ee77699443dd5cf2d157c151002ee9ca93922e44e134270ec9d6

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:45 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
x-evy-trace-route-service-name: envoyset-translator
x-hubspot-correlation-id: cd1b6dea-64e1-414e-8a43-6f286ec3ca57
content-encoding: br
x-envoy-upstream-service-time: 52
x-evy-trace-route-configuration: listener_https/all
x-evy-trace-listener: listener_https
x-request-id: cd1b6dea-64e1-414e-8a43-6f286ec3ca57
server: cloudflare
vary: origin
access-control-allow-methods: GET, OPTIONS, PUT, POST, DELETE, PATCH, HEAD
content-type: application/json;charset=utf-8
access-control-allow-origin: https://www.businesswire.com
x-evy-trace-virtual-host: all
cache-control: max-age=0, no-cache, no-store
access-control-allow-credentials: false
x-evy-trace-served-by-pod: iad02/star-hubspot-td/envoy-proxy-9fd6b4b-t8zkp
access-control-max-age: 180
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=WvsVKKh3MX9acqwI1IMdhu8duNW0MR3noWr6E7EZsoUGQ%2BHT%2BfiIm%2BqHEv4zYAeOLf36d%2BDlMvAy%2BXGQaLJhj%2FAolV1ngTtH1u0RESWHAFH5zlnndgQyHgVkq171rh3a1ELDofzkdwHeIlyHbcyE"}],"group":"cf-nel","max_age":604800}
x-robots-tag: none
access-control-allow-headers: Accept, Accept-Charset, Accept-Encoding, Accept-Language, Content-Type, Host, Origin, Referer, User-Agent
cf-ray: 87c16aa5abbd3664-FRA

GET
H2 200 favicon.ico
www.businesswire.com/ 15 KB
15 KB 104ms
103ms Other
image/vnd.microsoft.icon 184.24.28.52
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://www.businesswire.com/favicon.ico

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

184.24.28.52 Amsterdam, Netherlands, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-24-28-52.deploy.static.akamaitechnologies.com

Software

Resource Hash

d9ba465f841294db092c01245290e6230e7eb6cec255f5014e7ad53e3c37b446

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

strict-transport-security: max-age=31536000; includeSubDomains
content-security-policy: frame-ancestors 'self'
referrer-policy: no-referrer-when-downgrade
date: Mon, 29 Apr 2024 18:39:45 GMT
last-modified: Thu, 28 Mar 2024 18:37:06 GMT
etag: "e026c-3aee-614bccf625880"
x-frame-options: SAMEORIGIN
content-type: image/vnd.microsoft.icon
cache-control: max-age=71242
accept-ranges: bytes
content-length: 15086
x-xss-protection: 1; mode=block
expires: Tue, 30 Apr 2024 14:27:07 GMT

GET
H/1.1 200 fb79b04985 Show response
bam.nr-data.net/1/ 79 B
628 B 329ms
245ms Script
text/javascript 162.247.243.29
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://bam.nr-data.net/1/fb79b04985?a=116575036&sa=1&v=1071.385e752&t=Unnamed%20Transaction&rst=6321&ref=https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%25C2%25AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production&be=3133&fe=6179&af=err,xhr,stn,ins&perf=%7B%22timing%22:%7B%22of%22:1714415979297,%22n%22:0,%22f%22:737,%22dn%22:774,%22dne%22:774,%22c%22:774,%22s%22:843,%22ce%22:1016,%22rq%22:1017,%22rp%22:1267,%22rpe%22:1275,%22dl%22:1271,%22di%22:2351,%22ds%22:2373,%22de%22:2390,%22dc%22:6177,%22l%22:6177,%22le%22:6197%7D,%22navigation%22:%7B%7D%7D&ja=%7B%22ip_address%22:%2280.255.7.118%22%7D&jsonp=NREUM.setToken
Requested by: Host: js-agent.newrelic.com
URL: https://js-agent.newrelic.com/nr-1071.min.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 162.247.243.29 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: envoy /
Resource Hash: f2205c30ab0d0a86cd0d715cf483bafd550c0ea9d4ddb24e2c182f1d7f024144

Request headers

sec-ch-ua: "Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production
Accept-Language: de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile: ?0
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform: "Win32"

Response headers

date: Mon, 29 Apr 2024 18:39:45 GMT
server: envoy
access-control-allow-methods: GET, POST, PUT, HEAD, OPTIONS
content-type: text/javascript
access-control-allow-origin: *
access-control-expose-headers: Date
access-control-allow-credentials: true
x-envoy-upstream-service-time: 2
cross-origin-resource-policy: cross-origin
Connection: keep-alive
timing-allow-origin: *
Content-Length: 79
x-served-by: cache-fra-etou8220141-FRA

Verdicts & Comments Add Verdict or Comment

237 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

29 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

Domain/Path	Expires	Name / Value
www.businesswire.com/portal/site/home/template.BINARYPORTLET/permalink/resource.process	1969-12-31 23:59:59	Name: f5avraaaaaaaaaaaaaaaa_session_ Value: GMOFODPDAJLODIBPIDAFBBAAOPBIHDBDGLGCCFCPKNKAJOBLAIKEMEENNALMMHKADFIDJBIJDJIIBDCEADPADOJBCOICHFKJEDEGIGGCDACMOEACEDDAHHOFIKBEBLOD
www.businesswire.com/js/one_trust/consent/a2007379-c22b-41e8-8743-1bbfd2cbb24a	1969-12-31 23:59:59	Name: f5avraaaaaaaaaaaaaaaa_session_ Value: NMINMCLGCEIINBFGOAKNNNNKNBODNAPACFNEGKGKPHBLOEMOOPOELMKECJCCHBLJCPPDEHIGBJAPKOPCMNMAKMDHCOINLEOGJNIPIPKHGLCEPPICJKEEHOJKILNAMIEE
www.businesswire.com/js/one_trust/scripttemplates/6.4.0/assets	1969-12-31 23:59:59	Name: f5avraaaaaaaaaaaaaaaa_session_ Value: CJHMDAFDBJPIMMAHNGPFHNEANDKJHMGACDPAKLHDECJOMBLIPLEKJFMNNCGBDCGOEGADNNHODJJFINEDHNJAJPHGCOCNGIJIKKFFFMIKOCILDDIFBAILGEIDGPFKBMGN
.businesswire.com/	1969-12-31 23:59:59	Name: portal.JSESSIONID Value: XTIrJ9ZpMwJZEhHTXyzC96Jh1cClsrndNW1Okn1H9PLDDzEVkdWv!-93462612!389315169
.businesswire.com/	1969-12-31 23:59:59	Name: TS01d0bfe4 Value: 0102e294402e4ad781ff0d43dc8edaaf8d64ca8b7b76b3329a773cf01037c976f9ae46b25bd268172aaa69f0224347342bc4254dc0ac918dd80a8e5271cc0e302db8e5828687972b6a11c93186338b31dc343154a5
.businesswire.com/	1970-01-20 20:13:43	Name: bm_mi Value: F1E5C16F3DDA80B86D2C1D2CEB8FF1A2~YAAQXsMTAiGwcfiOAQAAn9YnKxdNuCzUGL/IjcoWrK+NHrasRBjEslx2fGigO4skIcGUrJUZ/SbVT7LoKLL3d6V8pqulmusp07kPNTdXHbzg4WYVRPCKTRTJCL/NTzj3lVGGOiEY+Ns91XrJ8K8ccOzNVjnM01VjwvdBD64NsjwdLdiLRyGEfMCNQSwsLEzyOP4MCg/zAwNjRk36UA5QlML7xwXGJcmFwfjUCXmqTkCSdtPrIGvUHZr9QoBKWdImsDqbpNfEgznk4/xvRExATdsVn2MVJolJpPmZuzWWIrz0RgLBlT+rDLoRizN6knmQXdMpRfntTOqdUvzTgsyOex33mS1uNN9VXc6QVxVnHTrYDY04hm3b+XGyzrNkspF2o55KYLt+hLsDlvd1sKayYEDI2xLmeug=~1
www.businesswire.com/	1969-12-31 23:59:59	Name: TS01c09a27 Value: 0102e294409532bd5005e630fd4020470e5ce5e8f076b3329a773cf01037c976f9ae46b25bd268172aaa69f0224347342bc4254dc031db38e1dd9afa9a81f5baf71bab4d48
.businesswire.com/	1970-01-20 20:13:43	Name: bm_sv Value: 4CC7BA558E4DDE285022F7A273E3F7E5~YAAQXsMTAiCwcfiOAQAAntYnKxdb0DihNt4XrvBX7ssdnRel0sbmLav4wn2NZH/ncMefNS8pF84OII84M8OGvF80ePioPHfyJkaZEuFlRFqRk921KLKiT6kQQK3SK5wCgU8wAd4RCT7q8NfC2OBHfVAdgqe0lXFORTzd5/V03J2Q+hN89fVYt528Oh6rHCLCgtFojftRMhc2GsiDHWjPuWXb0ow2RMoBUd4VDDuNRsiNFeK2p/vYD3wPzN9c0N4frSvW5Lto~1
.businesswire.com/	1970-01-21 04:59:11	Name: OptanonConsent Value: isIABGlobal=false&datestamp=Mon+Apr+29+2024+20%3A39%3A42+GMT%2B0200+(Mitteleurop%C3%A4ische+Sommerzeit)&version=6.4.0&hosts=&consentId=c0cc4b4f-46ad-4cfa-89ce-47320c9c7caa&interactionCount=0&landingPath=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20240418722567%2Fen%2FTriLink-BioTechnologies%25C2%25AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production&groups=C0001%3A1%2CC0003%3A1%2CC0002%3A1%2CC0004%3A1%2CC0005%3A1
.businesswire.com/	1970-01-20 20:13:43	Name: ak_bmsc Value: 2FEBE53520D4BC6ED08832150F167244~000000000000000000000000000000~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
.businesswire.com/	1970-01-20 22:23:11	Name: _gcl_au Value: 1.1.483912055.1714415983
.businesswire.com/	1970-01-21 05:49:35	Name: _ga Value: GA1.1.594054144.1714415983
.hsforms.com/	1970-01-20 20:13:37	Name: __cf_bm Value: JRiaynTfcavaACAZqG86680DCImlr68dN99yJjuTht8-1714415983-1.0.1.1-0TZJb7UiDdsUDgFETjpHMqTDjJ6COgZ6kj1VpCwUNOrd_k6mD9sWYWorJhTfLA54ETyaDnL05RU9e1QzLKMgGg
.hsforms.com/	1969-12-31 23:59:59	Name: _cfuvid Value: VRbHjz7FcryBzuYNh3tfVzDT0DWHCm3_0nlGET0G4Yc-1714415983778-0.0.1.1-604800000
.linkedin.com/	1970-01-20 22:23:11	Name: li_sugr Value: 7800334a-b944-4da6-9c08-fd6a1a368a42
.linkedin.com/	1970-01-21 04:59:11	Name: bcookie Value: "v=2&912a62d9-dddc-4c2b-8e55-d87b27a0de79"
.linkedin.com/	1970-01-20 20:15:02	Name: lidc Value: "b=VGST04:s=V:r=V:a=V:p=V:g=3217:u=1:x=1:i=1714415984:t=1714502384:v=2:sig=AQEZ_1nz-XGIfb2DMcIKMMZ-Ncdk3brT"
.linkedin.com/	1970-01-20 20:56:47	Name: UserMatchHistory Value: AQJKQ5-W00M_EAAAAY8rJ-DAMYDE0IrRioWmKkNJKKSnvhj056fD64ZV_Is8ofiV1MyF6VJY7KiqEA
.linkedin.com/	1970-01-20 20:56:47	Name: AnalyticsSyncHistory Value: AQKRLOqH_dJcrQAAAY8rJ-DAkuYYQAfjrAUejM-l6uJJf3hP7-GogCEYzcbRrBwVbCCTPE7HY4FCg8NvGKMicQ
.www.linkedin.com/	1970-01-21 04:59:11	Name: bscookie Value: "v=1&20240429183944f5a5c5e6-b7e1-4100-8a07-42a10bcc2307AQG0-8WHKFDB9jwPJ-dOKRbnuNXD9ug4"
.linkedin.com/	1970-01-21 00:32:47	Name: li_gc Value: MTswOzE3MTQ0MTU5ODQ7MjswMjHW4kHut/1CANoX3ZBV9SfEXyxKlYd9zMFXN/8p4bf6Ow==
.businesswire.com/	1970-01-21 00:32:47	Name: __hstc Value: 241090844.647017c5d3545be16452baf791365a4e.1714415985481.1714415985481.1714415985481.1
.businesswire.com/	1970-01-21 00:32:47	Name: hubspotutk Value: 647017c5d3545be16452baf791365a4e
.businesswire.com/	1969-12-31 23:59:59	Name: __hssrc Value: 1
.businesswire.com/	1970-01-20 20:13:37	Name: __hssc Value: 241090844.1.1714415985482
.businesswire.com/	1970-01-21 05:49:35	Name: _ga_ZQWF70T3FK Value: GS1.1.1714415983.1.0.1714415985.58.0.0
.hubspot.com/	1970-01-20 20:13:37	Name: __cf_bm Value: 9O15tWtjldFl6ybgNiiHMJLQJx._C.byk9CKjCr4H58-1714415985-1.0.1.1-PKWfktl7ewjQUWMk7yHsfElHO3iXhkpOnLaLWYr6C96CX2Dgkuu66H5Lr.U1uj_fsr6D1BJeZJejUlvMlClDQg
.hubspot.com/	1969-12-31 23:59:59	Name: _cfuvid Value: dz6QdtemnE1mY8OKhNgBGkMmauN5LGwtH_njTBDPH8A-1714415985765-0.0.1.1-604800000
.nr-data.net/	1969-12-31 23:59:59	Name: JSESSIONID Value: 4afacaa801aa8d13

40 Console Messages

A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.

Source	Level	URL Text
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://www.businesswire.com/news/home/20240418722567/en/TriLink-BioTechnologies%C2%AE-Announces-New-San-Diego-Facility-for-Late-Phase-mRNA-Drug-Substance-Production Message: Third-party cookie will be blocked. Learn more in the Issues tab.

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
Content-Security-Policy	frame-ancestors 'self' frame-ancestors 'self' frame-ancestors 'self'
Strict-Transport-Security	max-age=31536000; includeSubDomains max-age=31536000; includeSubDomains
X-Frame-Options	SAMEORIGIN SAMEORIGIN SAMEORIGIN
X-Xss-Protection	1; mode=block 1; mode=block

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

analytics.shareaholic.com
api.hubapi.com
api.hubspot.com
api.ipify.org
bam.nr-data.net
cdn.openshareweb.com
cdn.shareaholic.net
cta-service-cms2.hubspot.com
forms.hubspot.com
geolocation.onetrust.com
js-agent.newrelic.com
js.hs-analytics.net
js.hs-banner.com
js.hs-scripts.com
js.hsadspixel.net
js.hsleadflows.net
js.hubspot.com
js.usemessages.com
mms.businesswire.com
perf-na1.hsforms.com
px.ads.linkedin.com
px4.ads.linkedin.com
region1.analytics.google.com
snap.licdn.com
stats.g.doubleclick.net
track.hubspot.com
www.businesswire.com
www.google.de
www.googletagmanager.com
www.linkedin.com
www.shareaholic.net
www2.biocom.org
104.19.175.188
13.107.42.14
162.247.243.29
172.217.16.200
172.67.74.152
172.67.74.24
18.208.125.13
184.24.28.52
184.73.100.94
2001:4860:4802:34::36
216.58.206.67
2602:816:5001::39
2606:4700:20::681a:69f
2606:4700:4400::6812:22e5
2606:4700:4400::ac40:9b77
2606:4700::6810:4c8e
2606:4700::6810:7674
2606:4700::6810:89d1
2606:4700::6811:80ac
2606:4700::6811:afc9
2606:4700::6812:8d11
2606:4700::6812:f46c
2620:1ec:21::14
2a00:1450:4001:806::2008
2a00:1450:400c:c02::9d
2a02:26f0:3500:16::215:1484
3.218.230.104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www.businesswire.com Open in urlscan Pro 184.24.28.52 Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page Title

Page URL History Show full URLs

Detected technologies

Page Statistics

88 Requests

99 %HTTPS

59 %IPv6

24 Domains

32 Subdomains

27 IPs

5 Countries

7984 kBTransfer

11172 kBSize

29 Cookies

54 Outgoing links

Page URL History

Redirected requests

88 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 4 data transactions

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

www.businesswire.com Open in urlscan Pro
184.24.28.52 Public Scan

Screenshot
Live screenshot

Full Image

88
Requests

99 %
HTTPS

59 %
IPv6

24
Domains

32
Subdomains

27
IPs

5
Countries

7984 kB
Transfer

11172 kB
Size

29
Cookies

88 HTTP transactions
4 data transactions